1. FY26 Business Performance

Operational Scorecard (FY2026)

The following table summarizes the key operational metrics that drove business performance in FY26 of

• ICICI Prudential Life Insurance Company

• SBI Life Insurance Company

• HDFC Life Insurance Company

FY26 Performance Analysis

• The Growth Leader (SBI Life): SBI Life continues to be the only company delivering a “Double-Double”—double-digit growth in both sales (13%) and profitability (12%). Its massive distribution network (Bancassurance) allows it to maintain a industry-leading 27.5% VNB margin, showing that it can grow fast without sacrificing quality.

• The Efficiency Play (ICICI Prudential): ICICI Pru presents a fascinating story. Its top-line sales growth was nearly stagnant at 2.2%, yet its Value of New Business (VNB) grew by 10.9% and its Net Profit jumped by a massive 34.6%. This indicates a successful pivot: they are selling fewer but far more profitable products and aggressively cutting operational costs.

• The Defensive Fortress (ICICI Prudential): With a 227.3% Solvency Ratio, ICICI Pru is the safest “fortress” in the sector. This high capital buffer suggests they have significant room to increase dividends or reinvest aggressively when market conditions improve.

• The Resilience Story (HDFC Life): HDFC Life faced a tougher year, with VNB growth lagging at 2%. Regulatory impacts on their specific product mix (Annuities and Protection) acted as a drag. However, their 8% APE growth shows they are still successfully defending their market share.

2. Valuation Analysis: Market Cap vs. Intrinsic Value

Valuation Matrix (FY2026)

Analysis of the Valuation Gap

• The SBI Life: The most striking takeaway is that SBI Life is the cheapest stock despite being the best performer. It has the highest internal compounding rate (19.7% RoEV) but trades at the lowest multiple (1.32x P/EV). The market is effectively pricing it at a discount, likely due to its PSU-parentage perception, creating a classic “Growth at a Reasonable Price” (GARP) opportunity.

• The HDFC Premium: HDFC Life remains the most expensive stock at 2.07x P/EV. Investors are clearly paying a “brand and pedigree premium.” Despite lower RoEV than SBI Life, the market values HDFC’s sophisticated product mix and dominant retail presence, resulting in a high P/VNB of 31.87x.

• The ICICI Pru Stability: ICICI Pru sits at a fair 1.46x P/EV. Its valuation reflects its current status as a stable, high-solvency player with lower RoEV (11.9%). However, if its high PAT growth continues, it is the prime candidate for a valuation “re-rating.”

3. Identifying the Opportunities

SBI Life

SBI Life represents a absolute value play. A company compounding its internal value (RoEV) at nearly 20% while trading at just 1.32x its book value (P/EV) is an opportunity.

• This is not just “relative value” because it’s cheaper than HDFC; it is real value. SBI Life’s VNB margin of 27.5% is the highest in the sector, yet its P/VNB multiple (27.45x) is the lowest.

• For long-term portfolios, SBI Life offers the best “Safety Margin.” You are buying the industry’s most efficient growth engine at a discount price.

ICICI Prudential

The opportunity in ICICI Pru is a valuation re-rating play. While its current RoEV (11.9%) justifies its lower 1.46x P/EV, the massive 34.6% PAT growth suggests that the company has fixed its cost structure.

• There is hidden value here. ICICI Pru has essentially “over-capitalized” its balance sheet (227.3% Solvency). This extra capital is currently a drag on RoEV, but it provides the company with “dry powder” to either hike dividends significantly or fund an aggressive acquisition without needing fresh equity.

• This is a play for investors betting on a “Mean Reversion.” If that profit growth eventually drives RoEV toward 15%, the stock could re-rate from a 1.4x multiple to a 1.8x multiple.

HDFC Life

HDFC Life is currently a momentum and brand play, but the FY26 numbers suggest caution. Trading at 2.07x P/EV (a 56% premium over SBI Life) while its VNB growth has slowed to a mere 2% creates a potential “Expectation Gap.”

• This is relative overvaluation. While HDFC Life is a high-quality business with superior 61-month persistency (64%), the stock market is charging a “perfection premium.” For the current price to be “real value,” VNB growth needs to accelerate significantly to catch up with its high P/VNB multiple of 31.87x.

• HDFC Life remains a core “blue-chip” hold, but at current levels, it offers the least “valuation upside” compared to its peers.

Summary Comparison for Stock Investors

• Highest Upside Potential

  • SBI Life — Highest growth (20% RoEV) at the lowest price (1.3x P/EV)

• Downside Protection

  • ICICI Pru — Strongest capital buffer (227% Solvency) and massive profit growth.

• Brand & Stickiness — HDFC Life — Best long-term customer retention and premium product engine.

Don’t like what you are reading? Will do better. Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

This analysis relies on Q2 FY26 business updates from 10 companies

• Fashion — Trent, V2 Retail, Baazar Style Retail, Sai Silks (Kalamandir)

• Jewellery — Kalyan Jewellers, PC Jeweller, P N Gadgil Jewellers

• Grocery/hypermarket — Avenue Supermarts (DMart)

• Beauty — Nykaa (FSN E-Commerce)

• FMCG — Hindustan Unilever (HUL)

Insights reflect this sample, not the entire sector.

1. What Q2 FY26 Says About India’s Shopper

• Value & ethnic fashion clocked 17–86% YoY growth (Trent 17%; V2 86%; Baazar Style 71%; Sai Silks 28%) on Tier-II/III demand and early festive timing.

• Jewellery shone with ~30–65% growth (Kalyan ~30%; PNG ₹618 cr festive sales +65%; PCJ +63%) despite high gold prices.

• Beauty & e-commerce (Nykaa) re-accelerated — GMV in the “thirties,” net revenue mid-20s; fashion vertical regains momentum.

• Grocery/hypermarket (DMart) delivered +15% YoY on a high base; network at 432 stores.

• FMCG (HUL): near flat–low single digit growth due to short-term GST-led channel reset; medium-term tailwind as 40% of portfolio shifted to 5% GST.

Q2 shows decisive—not uniform—spending: discretionary outperformed staples, but GST reform sets up a staples catch-up from November.

2. Value & Ethnic Fashion

Tier-II/III Is the New Growth Core

Trent (Westside, Zudio)

• Revenue (incl. GST): ₹5,002 cr (+17% YoY); H1: ₹10,063 cr (+19%).

• Network: 261 Westside, 806 Zudio (incl. 3 UAE), 34 other formats; 40 net Zudio adds in Q2.

• Theme: premium-value barbell (Westside + Zudio) with rapid rollout and strong brand salience.

V2 Retail

• Revenue: ₹705 cr (+86% YoY); H1: ₹1,334.9 cr (+68%).

• SSSG: 23.4% reported; ~10.3% normalized (Durga Puja pull-forward).

• Network: 259 stores; ~27.9 lakh sq ft; 43 adds in Q2 (70 in H1).

• Theme: disciplined inventory, data-led assortment, limited markdowns → operating leverage.

Baazar Style Retail

• Revenue: ₹531.9 cr (+71% YoY); H1: ₹909.7 cr (+55%).

• SSSG: 22% (19% normalized); PSF: ₹865/month.

• Network: 250 stores, 22.96 lakh sq ft; 20 adds (Q2), 42 adds (H1).

• Theme: Eastern India scale-up with improving productivity.

Sai Silks (Kalamandir) — Ethnic Apparel

• Turnover: ₹444 cr (+28% YoY); H1: ₹823 cr (+34%).

• Openings: 5 stores in Q2; 10 more planned before festive peak.

• Formats: Kalamandir, VaraMahalakshmi Silks, Mandir, KLM Fashion Mall (ethnic + value fashion).

Value & ethnic fashion was Q2’s velocity leader: range 17–86% YoY. The flywheel: Tier-II/III rollout → SSSG (normalized) → better PSF → operating leverage.

3. Jewellery

Festive & Weddings Overpower Gold Price Headwinds

Kalyan Jewellers

• Consolidated growth: ~+30% YoY; India: +31% with ~16% SSSG; International: +17% (ME +10%).

• Candere: +127% YoY; network: 436 (India 300, ME 38, USA 2, Candere 96).

• Additional: continued deleveraging; collateral releases; fresh showroom launches.

PC Jeweller

• Revenue: +63% YoY; debt: –23% QoQ; >50% cut since FY25; track to debt-free FY26.

• Expansion: franchise-owned showroom (Pitampura, Delhi) — calibrated growth.

P N Gadgil Jewellers (PNGJL)

• Festive sales: ₹618 cr, +65% YoY (Navratri ₹428 cr +66%; Dussehra ₹190 cr +64%).

• Volumes: Gold +10%; Diamond +53%; Silver +64% (revenue: Gold +64%; Diamond +47%; Silver +133%).

Jewellery delivered broad-based growth (store adds + digital + volumes) even with gold at highs — underlining wedding/festive inelasticity and brand trust.

4. Beauty & E-Commerce

Nykaa’s Re-Acceleration

• GMV: “close to thirties” (~30–35% YoY); net revenue: mid-20s YoY.

• Beauty: 10+ consecutive quarters of mid-20s growth.

• Fashion: NSV “higher mid-twenties”; net revenue “low twenties” (ad income lag).

• House of Brands: Dot & Key, Kay Beauty, Nykaa Cosmetics fuel mix/margin.

• Tailwinds: early festive start; GST reforms lift disposable income.

Nykaa’s growth engine is balanced again (Beauty + Fashion) with brand IP driving profitability.

5. Grocery & Hypermarket

DMart’s Consistency Compounds

• Revenue: ₹16,218.8 cr, +~15.4% YoY.

• Network: 432 stores (one under reconstruction).

• Theme: everyday-low-price model; steady footprint expansion; high cash conversion.

DMart remains the sector’s execution benchmark — dependable mid-teens growth on a large base.

6. FMCG & Household Essentials

HUL’s GST Reset (Short-Term Pain, Long-Term Gain)

• GST change: From 22 Sept, ~40% of portfolio (soaps, toothpaste, shampoo, hair oil, talc, lifestyle nutrition, foods) cut to 5% GST (from 12–18%).

• Near-term impact: channel disruption (distributors/retailers clearing old MRP); Q2 growth near flat–low single digit; effect spills into October.

• Outlook: recovery expected from November as prices stabilize and pantry-loading resumes.

The staples pause is transitory; affordability tailwind likely to support volumes through FY26–27.

7. Cross-Sector Themes: What Changed This Quarter

• Festive pull-forward: Calendar effect (Durga Puja/ Navratri in Sept) shifted demand from Q3→Q2 for fashion/jewellery.

• Tier-II/III dominance: Majority of store adds outside metros; value-fashion & ethnic brands scaling faster in smaller cities.

• Deleveraging & discipline: Multiple players (PCJ, Kalyan, V2) tightened balance sheets; markdowns limited.

• Assortment intelligence: Data-led curation/replenishment → better sell-through, healthier PSF.

• Divergence → convergence: Discretionary outperformed staples; expect re-sync by Nov–Dec as GST effects fade and HUL rebounds.

The market rewarded footprint quality, inventory discipline, and pricing credibility more than raw footfall.

8. Investor Lens — Positioning Into H2 FY26

• Momentum bucket: V2 Retail, Baazar Style, Kalyan — fastest top-line trajectories with footprint expansion.

• Compounding bucket: Trent, DMart — consistency, scale, cash generation; defendable moats.

• Turnaround/Inflection: PC Jeweller (debt), HUL (GST reset → demand tailwind).

• Digital hybrids: Nykaa, Candere — brand portfolios with improving unit economics.

The consumption basket is tilting toward discretionary durability (fashion/jewellery) with staples catch-up likely into Q3/Q4.

Q2 FY26 was discretionary-led and Tier-II/III-powered. With GST-driven affordability improving, expect staples to re-accelerate and the overall retail flywheel to spin faster into the festive peak.

Don’t like what you are reading? Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

1. Q1-FY26 Short Take

• Record presales at DLF, Prestige, Sobha, Signature Global.

• Lodha, Godrej steady; supply timing remains the constraint.

• Balance sheets strong; debt costs trending lower.

• Offices stable, malls resilient, hotels rebounding.

• Outlook: Bullish cycle intact, but execution and approvals are the swing factors.

2. Demand Trends — Market Themes

Residential sales velocity remained vigorous, with multiple developers achieving all-time high bookings in Q1 FY26. Broadly, pricing power and premiumization were evident

• Premiumization is evident as developers like Signature, Brigade, Oberoi, and Phoenix achieved higher realizations, supported by strong demand for upscale projects.

• The NCR market surged, with Prestige, Sobha, and others reporting exceptional sales in Gurgaon and Noida, making the region a key growth driver this quarter.

• Bengaluru remained a stronghold, contributing significantly to sales for Godrej, Prestige, and Lodha, reinforcing the city’s position as a steady demand center.

• Mid-income housing is reviving, with Lodha highlighting renewed strength in this segment even as luxury sales remain robust.

• Launch absorption stayed high, with most projects selling 70–90% of their inventory within weeks of launch, underscoring depth of demand.

• Sales run-rates are holding steady, as shown by Lodha maintaining ~₹275 Cr in weekly sales even during the seasonally weak July period.

• The industry consensus is clear: demand remains strong across cities, while supply and regulatory approvals are the only real constraints.

Overall, all top developers affirm that demand far outstrips supply in their markets – as Lodha’s CEO stated, sales for the leading players are “constrained by supply and not by demand,” implying that the onus is on developers to feed a hungry market.

3. Supply & Launches

Developers are scaling supply with large launch pipelines and fresh land deals, while staying cautious on approvals and execution.

Execution & Discipline

• Approvals remain the key swing factor: Lodha (EC), Sobha (OC), Prestige (Bangalore nods).

• Construction capacity being upgraded: Signature Global has onboarded top-tier contractors (Ahluwalia, Capacite) to accelerate township build-outs.

• Most developers report steady or early completions, highlighting execution confidence.

Takeaway:

• Supply engines are accelerating, but carefully phased.

• Approvals and OCs remain the main bottleneck.

• Developers are matching demand without overbuilding, unlike past cycles.

4. Financial Health – Q1 FY26

Leverage & Liquidity

• Liquidity ample, leverage contained, financial discipline rewarded with ratings upgrades.

Cost of Debt

• Falling across the board:

• Developers expect further easing as RBI cuts transmit.

Profitability & Margins

• Sobha: EBITDA margin depressed (~8%) due to OC delays; pro forma PBT ~₹400 Cr if OCs recognized.

• DLF: Reported GM 28%, but embedded gross profit on Q1 sales ~₹4,500 Cr (~40%+ project margins).

• Lodha: Embedded EBITDA margin 33%; PAT margin ~21%; ROE ~20%.

• Accounting margins muted by timing, but embedded margins strong and will flow through as completions occur.

Takeaway

• Strong Collections & Cash Flows

• Developers are cash generative, low-levered, and funding growth without balance sheet stress.

• Falling cost of debt and rating upgrades improve financial flexibility.

• Embedded margins assure strong earnings recognition ahead.

• Sector financial health is materially stronger than in past cycles.

5. Annuity Engines – Q1 FY26

Annuity businesses are adding meaningful, steady cash flows and supporting valuations.

• Office and retail rental income is growing in the high single digits (with potential for faster growth as new assets lease up and repositioning yields benefits) – reflects confidence in future rental upsides.

• High occupancy across completed offices and malls signals that the top developers’ annuity assets are near optimal utilization, so incremental NOI growth will come from new developments and rent escalations – both of which are in play now.

• Many firms are in the midst of significant expansion of rental portfolios. Moreover, balance sheets can comfortably support these expansions: rental yields and refinance rates are such that companies like Phoenix and DLF can fund projects or acquisitions (like Phoenix’s CPPIB deal) without straining debt metrics.

• These annuity engines not only diversify revenue but also bolster developers’ resilience and valuations (with several exploring REITs/IPOs to surface this value).

Takeaway

• Offices near full occupancy at top players; strong leasing in new assets (DLF, Prestige, Brigade).

• Malls resilient; Phoenix using churn to upgrade tenants and drive future rent growth.

• Hotels rebounding strongly; new IPOs and REIT plans highlight monetization focus.

• Annuity portfolios provide steady cash flows, de-risk earnings, and support valuations.

6. Management Tone & Risks – Q1 FY26

Cycle View

Management commentary across the industry struck an optimistic chord, positioning the cycle as being firmly in an uptrend with more room to run. Lodha’s CEO described the sector as “in the early stages of a long up cycle”, underpinned by favorable macros, urbanization, and improved affordability.

Developers also emphasized that sales are limited by supply, not buyer interest – a refrain repeated by multiple CEOs. Indeed, a common theme was that whenever fresh quality inventory is launched, it sees near-instant absorption (with Oberoi quipping that in the interim between launches, sales naturally “plateau” until the next spike – “don’t read much into that”).

• Lodha: Sector is in the early stages of a long upcycle.

• Godrej: Euphoria is over; market now in a steady growth phase.

• Prestige: Sustained momentum; confident of beating guidance.

• DLF: Strong embedded margins/cash ensure resilience.

Approvals & Regulatory

• Lodha: Environmental clearance delays since Aug-24; Supreme Court resolution awaited.

• Sobha: OC delays deferred ~₹650 Cr revenue.

• Prestige: Key Bangalore launch dependent on approvals.

• Theme: Approvals remain the main gating factor for launches and revenue recognition.

Execution

• DLF: Weather-related delays impacted collections timing.

• Godrej: Upgrading contractors and digitizing labor management to lift execution run-rates.

• Signature Global: Brought in Grade-A contractors to accelerate township build-outs.

Pricing Discipline

• Lodha: Targets ~6% annual price increase, in line with affordability.

• Godrej: Holds premium stock to capture higher realizations.

• Oberoi: Ecosystem-driven pricing (integrated mall, metro, lifestyle assets).

Financing & Leverage

• Cost of debt easing across the board:

• Balance sheets strong; multiple credit upgrades (Brigade, Signature).

Consensus Risk View

• Demand remains strong and broad-based.

• Key risks are execution delays and approval bottlenecks, not demand or financing.

7. Cycle Outlook & Watchpoints

• The housing upcycle is intact: demand is strong, supply is lagging.

• Branded players are gaining share with record presales, strong collections, and healthier balance sheets.

• Approvals and execution are the real swing factors, not demand or financing.

• Stance: Bullish. Into Q2–Q3, watch three things — (1) approval timelines, (2) on-time execution of large pipelines, and (3) leasing ramp-up in offices/malls that can add steady cash flow torque.

Sources: Company Q1 FY26 Earnings Call Transcripts (DLF, Macrotech Developers/Lodha, Godrej Properties, Prestige Estates, Oberoi Realty, Phoenix Mills, Brigade Enterprises, Signature Global, Sobha Ltd.) etc.

Don’t like what you are reading? Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

1. The Announcement: Trump's 25% Tariff and Penalty on India

On Wednesday, July 30, 2025, Donald Trump announced a significant economic measure against India via a post on his Truth Social platform, sending shockwaves through the financial markets. Here are the critical facts investors need to know.

A. The Core Measure: A 25% Tariff on All Indian Goods

The central announcement is the imposition of a 25% tariff on Indian goods, set to become effective on August 1, 2025. Citing what he termed "among the highest in the World" tariffs from India and "strenuous and obnoxious non-monetary Trade Barriers," this move marks a dramatic escalation in US-India trade friction. The immediate effect will be a sharp increase in the cost of Indian products sold in the United States, directly impacting the competitiveness and profitability of Indian exporters.

B. The Geopolitical Layer: A "Penalty" for Russia Ties

In addition to the tariff, Trump included an unspecified "penalty" directly targeting India's strategic relationship with Russia. The announcement explicitly mentioned India's position as Russia's largest energy buyer and its continued purchase of Russian military equipment as the primary reasons. This dual approach transforms the issue from a standard trade dispute into a complex geopolitical event, adding a layer of unpredictable risk for investors.

2. Market Impact: What Indian Investors Should Expect Now

The announcement of US tariffs and penalties is set to trigger significant short-term reactions in the Indian financial markets. For investors, it's crucial to understand what to expect in the coming days and weeks. Here’s a breakdown of the likely immediate impact on the stock market, the rupee, and investor behavior.

A. Brace for Volatility in Sensex and Nifty

The primary and most immediate effect will be increased volatility in the Indian stock market. Benchmark indices like the BSE Sensex and Nifty 50 are expected to remain under pressure. While an initial drop is common, investors should prepare for continued sharp swings as the market reacts to every new development.

What to Watch For: The market will be highly sensitive to news. Any statement from US or Indian officials regarding trade negotiations could cause the indices to rise or fall sharply. Trading sessions may be characterized by uncertainty, making it a difficult environment for short-term traders.

B. Rupee vs. Dollar: Expect Continued Weakness

The Indian Rupee (INR) is expected to face downward pressure against the US dollar (USD). The logic is simple: tariffs threaten to reduce India's export earnings, which means fewer US dollars will be flowing into the country. This supply-demand imbalance typically leads to a weaker rupee.

Why This Matters to Your Portfolio:

The Negative: A depreciating rupee increases costs for Indian companies that import raw materials or have foreign currency debt, hurting their profits.

The (Limited) Positive: While a weak rupee can sometimes help exporters, the 25% tariff is likely to cancel out any potential benefit for companies in the affected sectors.

C. Watch for Shifting Investor Sentiment and FII Selling

In the short term, market direction will be dictated more by investor sentiment than by company fundamentals. A "risk-off" attitude is likely to dominate, where investors sell assets perceived as risky, like equities.

What to Expect: Keep a close eye on the activity of Foreign Institutional Investors (FIIs). It is common for FIIs to pull capital from a market facing geopolitical and economic uncertainty. This FII selling can add significant downward pressure on the entire market, impacting even fundamentally strong stocks. For the average investor, this highlights the danger of panic selling and the importance of focusing on long-term value.

3. Sectoral Impact: Identifying High-Risk and Defensive Industries

For investors, understanding which parts of the market are most exposed is critical. The impact will be felt unevenly across different sectors.

A. High-Risk Sectors: Directly Exposed to US Markets

Sector and Why It's at High Risk & Key Data Points

• Gems & Jewellery: Top Export Category — This is one of India's largest export categories to the US. The 25% tariff will crush margins and make Indian products significantly more expensive, risking a major drop in demand.

• Textiles & Apparel: High US Dependency — The US is a primary market for Indian garment and textile exporters. With capacity utilization already reported to be dropping, the tariff threatens to make a difficult situation worse.

• Auto & Auto Components: Direct Target — The automotive sector, accounting for roughly 3% of India's exports to the US, faces a direct hit on its competitiveness. Stocks in this space are highly vulnerable to order cancellations

• Chemicals & Engineering Goods: Broad Impact — These sectors are integral to the India-US trade relationship. The blanket nature of the tariff ensures they will face significant margin pressure and potential volume reduction.

• Information Technology (IT): Indirect Risk — While not tariffed, the sector faces risks from a potential US recession fueled by trade wars. Fears of reduced discretionary spending by US clients are already weighing heavily on IT stocks.

B. Potentially Insulated Sectors (Defensive Plays)

• Pharmaceuticals: Crucially, early reports suggest that the pharma sector, a cornerstone of India-US trade, might be spared from the harshest impacts, though this remains to be confirmed. Its essential nature makes it more resilient.

• Domestic Consumption: Companies in FMCG, Banking, and Utilities derive their revenue from the Indian domestic economy. They are largely shielded from this export-related crisis, making them potential safe havens for investors.

4. The Road Ahead: What Investors Must Watch For

The situation remains fluid. Long-term success will depend on navigating the next phase of this dispute.

A. Focus on US-India Negotiations

The future of this tariff hinges on trade negotiations. A US trade delegation's planned visit in mid-August is now a critical event.

• Key Sticking Points: Watch for news on long-standing issues, including US demands for access to India's agricultural (GMO) and dairy markets. Any sign of compromise could trigger a market rally.

B. Analyst Projections and Economic Forecasts

Market analysts are now modeling the economic damage. Early estimates, such as one from Macquarie, project a potential 50 basis point (0.5%) hit to India's GDP. Watch for downgrades in economic forecasts, as this will influence institutional investor sentiment.

C. The "China Plus One" Narrative

The only potential long-term silver lining is if these tariffs accelerate the "China Plus One" strategy, pushing global firms to shift manufacturing to India to de-risk their supply chains. Monitor for announcements of new Foreign Direct Investment (FDI) in Indian manufacturing.

5. Conclusion: An Investor's Action Plan

1. Don't Panic Sell: Making decisions based on fear is a losing strategy.

2. Review Your Portfolio for Exposure: Understand what percentage of your portfolio is in high-risk, export-oriented sectors. Rebalance if your risk exposure is too high.

3. Increase Allocation to Defensive Sectors: Consider moving capital towards high-quality companies in the domestic consumption, pharma, and FMCG sectors that are insulated from this trade war. Even consider moving to cash if you are unsure.

4. Stay Informed: Keep a close watch on the official news surrounding trade negotiations. The situation can change rapidly, and being informed will allow you to act rationally.

   ---

Don’t like what you are reading? Will do better. Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

1. Emerging Trends & Challenges

Premiumization is the dominant strategy across the board

• Hotel companies are choosing higher rates over higher occupancy — and it’s paying off.

• This shift is being led by both luxury players (Oberoi, Chalet) and mid-market chains (Lemon Tree, SAMHI), signaling sector-wide alignment.

• Investors should see this as a margin-protection strategy in a low-supply environment.

Leisure is now a structural growth pillar, not a seasonal blip

• Demand from vacationers, wedding guests, and spiritual travelers is proving more consistent than corporate bookings in many markets.

• Properties in places like Kaziranga, Ranthambore, and even Tier-2 cities are seeing sustained weekend demand.

• Leisure-first expansion is no longer just a hedge — it’s a primary growth lever.

Asset-light models are accelerating capital-efficient growth

• Chains are adding rooms through management contracts and long-term leases instead of heavy real estate capex.

• This model is allowing faster expansion with lower debt and better return on equity.

• For public market investors, this means higher growth with lower financial risk.

Tier-2 and spiritual destinations are emerging as serious markets

• Demand is shifting beyond metros, driven by infrastructure, rising incomes, and cultural tourism.

• Cities like Guwahati, Bhubaneswar, and Tirupati are appearing in growth pipelines — a trend that wasn’t mainstream five years ago.

• These markets offer lower cost structures and improving pricing power.

Non-room revenue — weddings, banquets, F&B — is quietly becoming the growth engine

• Many hotels are generating a significant share of profits from events and restaurants rather than just room rentals.

• Premium wedding venues, rooftop dining, and corporate MICE events are boosting TRevPAR and margins.

• Investors often overlook this vertical — but it’s a key differentiator for operators with strong event infrastructure.

Loyalty platforms and direct bookings are creating brand moats

• Hotel chains are investing heavily in owning the guest relationship — through apps, rewards, and referrals.

• This reduces OTA dependency and improves pricing control.

• In the long run, these digital ecosystems could become powerful revenue and margin levers.

Execution risk, not demand, is the biggest near-term challenge

• Demand is strong and broad-based — but supply is tight, approvals take time, and renovation downtime can hurt quarterly results.

• Some companies flagged temporary revenue softness due to macro events (e.g., border tensions, delayed weddings).

• The focus now is on balancing disciplined growth with market opportunity — avoiding overreach in a bullish cycle.

2. Demand Outlook: 2026 and Beyond

2.1 Short-to-Medium Term (FY26–FY28)

The industry is entering a high-confidence demand cycle

• Hotel CEOs across the board sound more optimistic than they have in years — not just because occupancy is back, but because pricing power is holding.

• Demand is now broad-based: business travel is recovering steadily, and leisure travel has proven sticky even in off-seasons.

Room demand is becoming more predictable, especially on weekends

• Leisure destinations are seeing stronger forward bookings — especially for weddings and events.

• Urban hotels are regaining their Monday-to-Friday business base, particularly in metro corridors with tech and corporate presence.

Non-metro markets are starting to matter more

• Operators are seeing early traction in places like Guwahati, Tirupati, Pavagadh — destinations that combine tourism potential with rising regional incomes.

• These markets were once considered fringe; now they’re part of core growth plans.

Fewer new rooms = more pricing power

• Everyone knows supply is tight — and that’s why rate growth is expected to continue.

• With most new hotels still a couple of years away from opening, the pricing environment remains favorable through at least FY27.

Loyalty and digital are making demand more defensible

• Chains investing in direct booking platforms are reducing reliance on discount-heavy OTAs.

• The result: steadier rate realization and lower customer acquisition costs — both of which support long-term demand stability.

2.2 Long-Term View (to 2030)

India’s hotel demand story is moving from cyclical to structural

• Rising incomes, a younger population, and better highways and airports are fundamentally reshaping the travel landscape.

• Demand isn’t just bouncing back — it’s expanding into new geographies, categories, and use cases.

Metro-first is dead. Diversified demand is the new default

• The old formula — build in Mumbai and Delhi, hope for spillover — no longer works.

• Hotel pipelines now include destinations like Guwahati, Pavagadh, Tirupati, and Kaziranga — not as experiments, but as core bets.

🔍 Investor angle: Expect higher ROI from early movers in Tier-2 cities and spiritual corridors with supply discipline.

Inbound tourism and international travel are slow-building tailwinds

• Inbound demand isn’t back in full yet — but hotel brands expect it to pick up meaningfully by 2027–2030.

• Premium properties near coasts, cities, or cultural hubs could benefit the most.

🧠 Optionality worth watching: Properties tied to global brands (Hyatt, Marriott, Oberoi) have upside leverage here.

Blended travel is the future — and it’s already here

• Business + leisure trips are converging. Guests may attend a meeting and stay an extra day with family.

• Hotels with wellness zones, kids’ activities, and flexible layouts are seeing stickier bookings.

📊 Revenue implication: Longer stays, higher per-room spend, and better weekend utilization.

Experience-first formats will outperform generic inventory

• Guests are seeking meaning, not just a bed. Wellness, heritage, nature, and spiritual travel are gaining share.

• Chains investing in differentiated formats — curated retreats, destination weddings, temple circuits — are positioning for multi-generational demand.

Execution is the bottleneck — not demand

• Strong demand doesn’t guarantee delivery. Timelines are slipping due to local regulations, environmental clearances, and labor shortages.

• Tier-2 markets can be unpredictable in approval cycles and capex execution.

⚠️ Investor takeaway: Focus on players with land secured, brands in place, and execution credibility — not just signed MOUs.

3. Hotel Room Supply Outlook

3.1 The current market remains supply-starved — and that’s not changing soon

• Most hotel companies are operating near peak occupancy

  • Across metro and resort markets, rooms are full on weekends, and even weekdays are stabilizing.

  • Yet new supply is slow to come online — giving operators more leverage on pricing and selection.

• The gap between demand and room inventory is now strategic

  • For years, India’s hotel supply has lagged demand, especially in high-growth business hubs and tier-2 cities.

  • Operators are using this imbalance not just to raise rates, but to be selective about what, where, and how they build next.

3.2 New supply is coming — but it’s cautious, phased, and smart

• Everyone has a pipeline — but no one’s in a rush

  • Hotel groups are announcing new keys, but with realistic 2–5 year delivery timelines.

  • This is a disciplined growth phase — not the speculative overbuild cycle seen in the past.

• Asset-light models are enabling room expansion without balance sheet bloat

  • Chains like Lemon Tree, EIH, and Mahindra are relying more on management contracts and leases to grow.

  • This reduces capital intensity and avoids the risks of land acquisition and construction in a volatile cost environment.

• Brownfield is the new greenfield

  • Many expansions are coming via conversions and rebranding of older properties — faster to execute and often higher ROI.

  • SAMHI, for instance, is unlocking value through brand upgrades rather than starting from scratch.

3.3 Tier-2 and leisure markets are getting more attention in the pipeline

• New projects are being planned in places that were ignored a decade ago

  • From Kaziranga to Guwahati to Varca in Goa, the next wave of hotels is expanding India’s travel map.

  • These cities are not just cheaper to build in — they also face less regulatory friction and have untapped demand.

• Regional diversification is becoming a supply-side hedge

  • Chains want to avoid overdependence on Delhi, Mumbai, and Bangalore.

  • Spreading out across leisure, spiritual, and business corridors allows more resilience — and a more consistent booking curve.

3.4 Execution and approvals remain the biggest roadblocks

• Land, licenses, and environmental clearances are still slow

  • Projects in Goa, Himachal, and some urban districts are seeing multi-year delays due to compliance bottlenecks.

  • Even well-funded players like Chalet and Juniper have called out these issues as key friction points.

• Renovation cycles are disrupting short-term inventory

  • Several large hotels are temporarily operating below full capacity due to room refurbishments and ballroom upgrades.

  • While positive for future pricing, this does reduce sellable room inventory in the short term.

3.5 Investor takeaway: growth is coming — but it’s controlled, not chaotic

• Most listed players are focused on profitable expansion, not just scale

  • There’s a clear shift toward quality of rooms over quantity.

  • Supply growth is calibrated — and that’s good news for rate integrity and margins.

• In this environment, being early matters

  • Operators that already have land, approvals, and branding locked in will enjoy a multi-year head start.

  • Investors should watch for those with executable pipelines, not just large announcements.

4. Pricing & Revenue Outlook

4.1 Rate-led growth is no longer optional — it’s the core strategy

• Operators across segments are prioritizing pricing over volume

  • Whether it’s Chalet in Mumbai or Lemon Tree in mid-markets, the mantra is clear: maximize average room rates (ARR), not just occupancy.

  • This shift reflects confidence in demand quality — and discipline in managing inventory.

• Occupancy is healthy — but room for upside is in price

  • Most hotels are already running at 70–80% occupancy on key days.

  • The big opportunity lies in lifting average daily rates, especially in markets with constrained supply.

4.2 The ability to raise rates is strongest where the brand and product are premium

• Premium brands are commanding meaningful price power

  • Operators like Oberoi, JW Marriott, and Aurika aren’t just selling rooms — they’re selling experience, design, and exclusivity.

  • That’s allowing double-digit rate hikes without customer pushback.

• Renovations and rebranding are setting up the next wave of rate growth

  • SAMHI’s upgrades in Pune and Jaipur are aimed at repositioning properties into higher rate brackets.

  • Juniper’s refurbished hotels in Hampi and Ahmedabad are already seeing better rate traction post-refresh.

4.3 Beyond rooms, revenue is being engineered across the guest journey

• Non-room income is becoming a real profit lever

  • Weddings, banquets, F&B, and events now account for a significant chunk of hotel revenue.

  • Properties with large event spaces, rooftop venues, and curated F&B are capitalizing on this premium revenue stream.

• Guest monetization is improving with digital tools and loyalty

  • Chains are learning how to upsell upgrades, offer dynamic pricing, and convert loyalty into higher wallet share.

  • Lemon Tree’s Infinity program and Mahindra’s member-driven model are both pushing this evolution.

4.4 Direct distribution is driving better pricing integrity

• Loyalty programs are reducing dependence on OTAs

  • OTAs may bring bookings, but they eat margins and weaken pricing power.

  • Operators are building ecosystems that drive direct bookings — improving yield and retention.

• Digital-first travelers are proving more profitable

  • Guests acquired through apps, referral links, and loyalty portals are booking faster, spending more, and complaining less.

  • The tech stack is now part of the pricing strategy.

4.5 Revenue visibility is improving — but so is scrutiny

• Bookings are becoming more predictable, especially for leisure and events

  • Hotels are seeing strong pipelines for weddings, offsites, and long weekends.

  • This advance visibility is helping operators optimize rates day by day, not quarter by quarter.

• Investors should track revenue mix, not just topline growth

  • A ₹10 Cr revenue bump driven by rooms is not the same as one driven by high-margin F&B or banquets.

  • Understanding this mix is key to projecting sustainable EBITDA.

4.6 The real upside lies in blending price, experience, and efficiency

• The best-performing chains are not just raising rates — they’re justifying them

  • Properties that invest in service, branding, and design are able to defend pricing power even in shoulder seasons.

  • This is where margins are won or lost.

• Rate-led growth is more resilient in downturns

  • When demand softens, a hotel built on pricing integrity can cut promos strategically — not desperately.

  • That makes rate-led models more defensive as well as more profitable.

5. Profitability Outlook

5.1 Margin expansion is real — and it’s being earned, not gifted

• Most hotel companies ended FY25 with record or near-record margins

  • This wasn’t luck or a one-off — it was the result of stronger pricing, controlled costs, and smarter operations.

  • EBITDA growth across players came not just from demand recovery, but from better rate realization and revenue mix.

• COVID-era cost discipline has permanently shifted the baseline

  • Several companies right-sized operations during the pandemic — and haven’t gone back.

  • That structural efficiency is now translating into durable margin improvement, even as revenue scales.

5.2 The strongest operators are building margin through design, not dependence

• High-margin revenue streams are being prioritized

  • F&B, weddings, and MICE events — once considered ancillary — are now core to the P&L.

  • These segments carry better margins than rooms, especially in premium properties with differentiated offerings.

• Premium pricing is translating into higher flow-through

  • Hotels that have invested in branding, product quality, and experience are seeing pricing power drop straight to the bottom line.

  • Chalet, Ventive, and SAMHI are already seeing this play out in flagship properties.

5.3 Brand upgrades and reconfigurations are margin multipliers

• Renovation is not just maintenance — it’s margin strategy

  • Properties under brands like Courtyard, Tribute, and Aurika are replacing older formats with higher-margin positioning.

  • These upgrades are designed to boost both ARR and guest spend per night.

• Rebranding gives operators a reason to reset pricing and retool operations

  • For players like SAMHI and Juniper, the goal is not just to modernize rooms — it’s to reposition the entire P&L over the next 12–18 months.

5.4 Tech and loyalty are quietly boosting profit per guest

• Direct bookings reduce commissions — and increase yield

  • Loyalty programs are not just about repeat visits — they also eliminate OTA margin drag and enable upselling.

  • Lemon Tree’s Infinity platform and Mahindra’s membership model are showing early margin impact.

• Smart analytics are helping optimize labor, inventory, and energy usage

  • Efficiency is no longer about austerity — it’s about intelligence.

  • The best-run chains are using data to balance cost and service with precision.

5.5 Capex is rising — but it’s increasingly return-focused

• Companies are spending — but spending wisely

  • The capital is going toward renovations, brand upgrades, and revenue-enhancing features — not just raw room additions.

  • Investors should view this as margin-accretive capex, not margin-dilutive overreach.

• Most new investments are tied to a clear ROI thesis

  • Whether it’s a new rooftop bar, a Marriott conversion, or a rebranded ballroom, companies are thinking in terms of payback, not vanity.

5.6 Risks exist — but the sector is better equipped to absorb them

• Inflation and staffing costs are creeping up

  • Labor, utilities, and food costs are expected to rise — but chains have better pricing tools and levers to protect margins.

  • Events like geopolitical shocks or seasonality dips may cause quarterly blips — but not structural margin erosion.

• Renovation downtime can distort near-term numbers

  • Several operators flagged temporary dips in F&B or room inventory due to upgrade work.

  • These are execution risks — but often signal better margins ahead, not worse.

Investor takeaway: This is no longer a low-margin, capital-heavy business

• Profitability is becoming strategic — not accidental

  • The best-performing chains are engineering their margins through rate strategy, revenue mix, and operational design.

  • This new margin playbook is more sustainable — and more scalable — than what the sector offered a decade ago.

• The market will reward those who grow margins while expanding

  • It’s not just about topline growth — it’s about expanding profit per room, per guest, and per square foot.

• That’s where the next leg of hotel sector outperformance will come from.

6. Appendix

Companies covered

• EIH Ltd (Oberoi Group) (eihltd.com | NSE: EIHOTEL)

• Chalet Hotels (chalethotels.com | NSE: CHALET)

• Ventive Hospitality

• Lemon Tree Hotels

• Mahindra Holidays & Resorts

• SAMHI Hotels

• Juniper Hotels

Primary source: FY25 earnings call transcripts

• Insights are drawn from Q4/FY25 earnings calls of 7 listed hotel companies.

• Transcripts reflect real performance, management strategy, and analyst Q&A.

Don’t like what you are reading? Will do better. Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

• Gold breached ₹1 lakh/10g for the first time — stretching budgets, pressuring volume.

• Weddings remained resilient — seasonal demand drove footfall across regions.

• Buyers evolved — higher old gold exchange, shift to 18k/14k jewellery, and lighter designs.

• Studded jewellery grew in entry price points — while solitaires faced demand caution.

• Organised players expanded deep into Tier 2–4 markets using asset-light franchise models.

• Inventory surged — not due to stockpiling, but sharp rise in gold prices.

• Margins held — driven by hedging, leverage, and working capital control.

• Shift underway: from weight to design, from purity to brand.

• Bottom line: FY25 was a mindset shift, not just a market shift.

2. FY25 Strategy Snapshot: How India’s Top Jewellers Stack Up

• Titan leads in premium positioning, product innovation, and balance sheet discipline.

• Kalyan is the most aggressive scaler via FOCO and new geographies.

• Senco is methodically building studded and franchise momentum while preserving margins.

• DP Abhushan is in early growth mode with focus on wedding and regional dominance.

• Thangamayil remains conservative, especially on new formats and product mixes.

3. Macroeconomic Context

• Gold soared to all-time highs (from ~₹6,300 to ₹1,00,000/10g) amid:

  • Central bank buying

  • Geopolitical risk hedging

  • Global economic uncertainty

• Weddings remained a macro driver:

  • ~1 crore weddings in India supported demand

  • Bridal budgets proved more resilient than discretionary gold spending

• Rising urbanisation and income in Tier 2–4 towns:

  • Organised players chased aspirational demand beyond metros

• Inflation manageable, but gold price hikes sharply visible

  • High-ticket discretionary purchases (e.g. solitaires) took a hit

  • Sub-₹1L purchases (e.g. gifting, daily wear) remained steady

• GML (Gold Metal Loan) costs rose to 6.6% in Q4 due to global disruptions

  • Firms used hedging and franchise-led growth to maintain working capital discipline

4. Demand Trends & Consumer Behavior

• Weddings drove topline across brands

  • Kalyan, Senco, DP Abhushan leaned heavily on bridal collections

• Volumes declined, ticket sizes rose

  • Titan: low growth in sub-₹50k buyers

  • Senco: 3–4% drop in gold volumes

  • Kalyan: wedding demand stable, discretionary demand soft

• Old gold exchange surged:

  • Senco: 40% of sales from exchange (vs. 25% two years ago)

  • DP Abhushan saw strong traction in Rajasthan/MP

• Shift in caratage and design

  • Rise in 18k/14k usage (especially in studded and fashion jewellery)

  • Titan, CaratLane, Senco exploring 9k diamond offerings

• Mixed momentum in studded jewellery

  • Titan: small-stone pieces rising; solitaires cautious

  • Senco: +38% value, +21% volume in Q4

• Buyer mindset evolving:

  • Repeat buyers growing share

  • Exchanges leading to upgrades

  • Gen Z prefers style, not weight

5. The Diamond Shift

• Entry-level diamond pieces booming

  • Titan, CaratLane, Senco seeing strong under-₹1L studded traction

• Solitaires sluggish:

  • Price volatility + investment doubts hurting demand

  • Titan reports buyer hesitation

• LGDs (Lab-Grown Diamonds): potential disruptor

  • Prices falling sharply; still not widely adopted by majors

  • Titan & Senco remain cautious, focus on natural diamonds

• Studded exchange behaviour:

  • Most customers upgrade — not downgrade to gold

  • No major distress selling trend seen

• Brand strategy shift:

  • More 14k/9k launches to lower entry barriers

  • Campaigns reframing studded as style, not just sparkle

6. Geographic and Channel Expansion

• Tier 2/3/4 cities = top expansion priority

  • Kalyan, Senco, DP Abhushan entered 20+ new small-town markets

• Store count surging:

  • Kalyan: 137 stores added in FY25; 170 planned for FY26

  • Senco: 16 stores in FY25; 18–20 more targeted

  • Titan: 40–50 new stores + 50–60 store upgrades planned

• FOCO (franchise-owned, company-operated) growing fast

  • Kalyan, Senco scaling via asset-light models

  • Thangamayil staying conservative

• Omni-channel focus deepening:

  • CaratLane, Candere, Everlite blending online + offline

  • Personalised discovery tools, digital marketing, remote shopping options growing

• International bets small but rising

  • Kalyan entered US

  • Titan prepping for UK

7. Capital Efficiency and Inventory Management

• Working capital ballooned due to gold inflation

  • Inventory value rose despite flat volume

  • Senco: inventory days up from 151 → 166

• GML use widespread but volatile

  • Rates peaked at 6.6%; now normalising near 5–5.5%

  • Titan has edge in pricing, hedging

• Inventory strategies evolved

  • Hyperlocal assortments

  • Faster design churn, especially studded

  • Seasonal readiness (Akshaya Tritiya, Diwali)

• Capital allocation priorities:

  • Kalyan cutting debt (target: ₹400 Cr in FY26)

  • Senco holding D/E flat at ~1.0x

  • Titan targeting long-term ROCE/ROE improvement

• Hedging essential

  • Titan and Senco leveraged forward contracts for margin protection

  • 60–80% hedge ratio typical

8. Competitive Landscape and Pricing

• Making charge competition heating up

  • Regional players offering deeper discounts

  • Organised brands holding price line, leveraging trust + service

• Differentiation via design

  • Titan: localised collections

  • Senco: 25k+ new designs; fashion-first lines (Everlite, Berry)

• Brand equity matters

  • Lifetime exchange, purity assurance, buying experience = key to consumer stickiness

• Sales teams + incentives driving upsell

  • Staff bonuses aligned to studded conversion

• Regional brands still present

  • But unorganised losing share in metros + large Tier 2 towns

9. FY26 Outlook

• Revenue growth expectations

  • Titan, Kalyan, Senco: 18–20%+ top-line

• Margin outlook:

  • Titan: steady at ~11.5%

  • Kalyan: aiming for >5% PBT

  • Senco: 6.8–7.2% EBITDA; 3.5–3.7% PAT

• Expansion targets:

  • Kalyan: 170 stores

  • Senco: 18–20 stores

  • Titan: 40–50 new + 50–60 upgrades

• Studded focus continues

  • Titan, Senco targeting studded ratio improvement

• Capital discipline

  • Inventory control, franchise scaling, cost management top priorities

• Risks to watch:

  • Gold volatility, GML rate swings

  • Rural softness or weak monsoon

  • Solitaires + LGD overhang on diamond margins

10. Structural Growth Drivers

• Organised share rising fast

  • Driven by GST, hallmarking, digital payments

• Weddings offer non-cyclical base

  • 8–10 million weddings annually = stable demand floor

• Gen Z changing jewellery perception

  • From dowry to design

  • From weight to identity

• Format innovation expanding access

  • Shop-in-shops, small-format outlets, gifting collections

• Omnichannel = default playbook

  • Online aids discovery; offline anchors trust

• Jewellery is both emotion + asset

  • Still valued for resale and legacy

11. Risks and Uncertainties

• Gold price swings

  • Delays purchases, impacts margins, strains inventory

• Margin headwinds

  • Higher GML rates, promotional pricing pressure, franchise dilution

• Demand volatility

  • Monsoon, elections, global macro can hit discretionary spends

• Diamond drag

  • Solitaires weak

  • LGD disruption unclear

• Regulatory shifts

  • GST hike or hallmarking reforms could hit industry

• Digital disruption

  • D2C brands, social-first discovery eating into legacy marketing

12. Conclusion

• FY25 forced evolution across the board

  • High prices tested demand

  • Brands leaned into insight, not just inventory

• Mindset > Metal

  • Winning players adapted to what consumers want, not what they used to sell

• Structural tailwinds remain intact

  • Weddings, Tier 2 wealth, Gen Z style, digital discovery

• FY26 watchlist:

  • Can solitaires rebound?

  • Will LGDs gain trust?

  • Will margins hold if gold stays volatile?

• Final word:

Jewellery is no longer just a product. It’s a platform for identity, trust, and growth.
The brands that treat it that way will lead the next decade.

---

Don’t like what you are reading? Will do better. Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

An analysis of India’s private sector banking landscape, based on Q4 FY25 earnings calls from the seven largest listed banks. Amid rising funding costs, macro uncertainty, and shifting credit dynamics, this report unpacks how each bank is now defined less by balance sheet size and more by execution, risk discipline, and franchise strength.

Banks covered:

• HDFC Bank (NSE: HDFCBANK)

• ICICI Bank (NSE: ICICIBANK)

• Axis Bank (NSE: AXISBANK)

• Kotak Mahindra Bank (NSE: KOTAKBANK)

• Federal Bank (NSE: FEDERALBNK)

• IDFC First Bank (NSE: IDFCFIRSTB)

• YES Bank (NSE: YESBANK)

We explore macro conditions, loan growth, asset quality, profitability, and capital — ending with a comparative dashboard of strategy and performance across the sector’s key players.

1. Executive Summary

• FY25 was a year of strategic recalibration, not reckless growth, for India’s private sector banks.

• Most banks reported healthy profitability and stable asset quality, despite macro and liquidity headwinds.

• Credit quality bifurcated:

  • Corporate loan books remained pristine.

  • Retail unsecured and microfinance portfolios showed stress, especially in Q3 and Q4.

  • Credit costs diverged, with some banks front-loading provisions.

• Margins (NIMs) mostly held up, but pressure is building due to:

  • Deposit repricing lagging behind lending rate resets.

  • Rising share of high-cost term deposits.

  • Softening of loan yields in secured retail.

• Deposit mobilization became critical:

  • CASA share fell at most banks; retail TDs became dominant.

  • Some banks cut SA/TD rates to protect NIMs ahead of expected RBI rate cuts.

• Profitability remained resilient:

  • ROA held above 1% for most large banks.

  • Fee income (cards, wealth, cross-sell) emerged as a key growth driver.

  • Cost control and tech productivity supported operating leverage.

• Strategic repositioning underway across the sector:

  • Kotak, Federal, and Axis focused on mid-yield, profitable retail and SME books.

  • HDFC Bank reorganized its asset side to drive synergy and productivity.

  • IDFC First shored up capital and slowed down MFI.

  • ICICI and YES focused on conservative growth and risk containment.

• Overall:

  • The private banking sector is healthy but cautious.

  • Risk-adjusted growth, cost efficiency, and customer franchise strength will define leadership in FY26.

2. Macro Backdrop: The Balancing Act

• RBI shifted stance from neutral to accommodative in late FY25:

  • Two repo rate cuts already executed.

  • Liquidity infusion measures (CRR tweak, durable liquidity steps) underway.

• Inflation within control:

  • Headline inflation cooled, creating space for monetary easing.

  • Food inflation remains a watchpoint, but core inflation trends are benign.

• Liquidity: From tight to easing

  • System liquidity was tight for most of FY25, easing only in Q4.

  • Banks faced intense competition for deposits across the year.

  • CASA growth was sluggish; TDs saw higher mobilization due to aggressive pricing.

• Rate cycle turns down:

  • Industry anticipates 50–100 bps of further repo cuts in FY26.

  • Banks preparing for margin pressure as loan repricing outpaces deposit cost resets.

• Global headwinds persist:

  • Trade disruptions, tariff uncertainty, and geopolitics could impact exports and credit demand.

  • Corporates remain in “wait and watch” mode for capex decisions.

• GDP outlook remains supportive:

  • FY26 growth expected from rural recovery, pre-election spending, and consumption rebound.

  • Bank credit demand likely to stay strong in mid-market and secured retail segments.

• Net effect:

  • Macro setup is favorable for credit growth but demands disciplined margin and liquidity management.

  • FY26 will be a test of pricing strategy, funding resilience, and underwriting agility.

3. Growth vs Profitability: Navigating a New Normal

• Loan growth across private banks remained steady:

  • Overall credit growth in the system ~15% YoY.

  • Private banks largely in line or ahead, led by SME, mid-corporate, and select retail segments.

• Retail lending saw a shift in mix:

  • Secured products (LAP, home loans, CV/CE, gold loans) saw strong traction.

  • Unsecured loans (PL, credit cards) moderated due to risk recalibration and regulatory focus.

• Corporate lending remained cautious:

  • Large-ticket corporate loans grew modestly due to pricing pressure from PSBs.

  • Mid-market and SME lending surged (Axis: +14% YoY; Kotak & Federal: +30%).

• Microfinance lending hit a wall:

  • IDFC First and Kotak sharply reduced exposure after stress and collection issues.

  • Structural reassessment of MFI business models now underway.

• Deposit growth outpaced loan growth at most banks:

  • Especially at HDFC Bank (to normalize CD ratio) and YES Bank (to rebuild franchise).

  • Axis, Federal, and Kotak also focused on granular retail deposit acquisition.

• Focus shifted from growth-at-all-costs to profitable growth:

  • Banks used internal RoA/RoE scorecards to prioritize yield, risk, and relationship depth.

  • Customer lifetime value and bundled relationships preferred over loan book volume.

• Guidance for FY26:

  • Double-digit loan growth expected, led by secured retail, SME, and ecosystem-based lending.

  • Unsecured retail growth to resume slowly, with tighter controls.

  • Corporate loan growth to track broader investment cycle revival.

4. Credit Quality & Credit Costs: The Divergence Widens

🔍 Corporate Book: Exceptionally Clean

• Minimal or no new slippages reported by Axis, ICICI, HDFC Bank, YES Bank.

• Recoveries, upgrades, and NARCL resolutions improved reported GNPA.

• 70–90% of corporate books rated A– and above (ICICI: 74.8%).

🛍 Retail Credit: Mixed Signals

• Secured retail (home, CV, LAP): Stable GNPA, well-collateralized.

• Unsecured retail (PL, cards):

  • Slippages peaked in Q3; signs of stabilization by Q4.

  • Kotak and Axis flagged moderation and tighter underwriting going forward.

  • Bounce rates improving, but delinquencies still elevated in some cohorts.

🚨 MFI Segment: Epicenter of Stress

• IDFC First: SMA 1 & 2 in MFI book at 5.1%, GNPA high.

• Kotak pulled back MFI portfolio significantly (–33% YoY).

• Federal also facing mild pressure; YES Bank avoiding MFI altogether.

• Collection efficiencies improving, but stress lingers.

📉 Credit Costs: Divergence Widens

• ICICI, HDFC Bank, Federal: credit cost in range of 30–45 bps.

• Axis: 50 bps, trending lower.

• Kotak: 60–65 bps, up YoY due to MFI.

• IDFC First: 2.46% total; 1.76% excluding MFI.

• YES Bank: improved due to cleanup and higher PCR.

🧱 Provision Buffers Remain Strong

• ICICI: ₹13,100 crore contingency provision.

• Axis: ₹5,012 crore general + ₹11,957 crore non-NPA provisions.

• Others (HDFC, Kotak, Federal) also maintain high PCRs (75–80%).

📌 Outlook FY26

• Retail credit quality expected to stabilize further.

• MFI to remain under close watch; banks are cautious on fresh exposure.

• Overall credit costs likely to trend toward 40–60 bps (ex-MFI) for most banks.

5. Margins, Fee Income & Operating Leverage

💰 Net Interest Margins (NIMs): Holding for Now

• ICICI: 4.41% (Q4FY25), stable.

• HDFC Bank: 3.46%, within long-term band.

• Axis: 3.97%, improved QoQ.

• Kotak: 4.96%, down YoY (was 5.3%+ last year).

• Federal: 3.12%, in line with guidance.

• IDFC First: 5.95%, but under pressure from rising deposit costs.

• YES Bank: improving, but still below private bank average.

🧨 Margin Pressure Building

• Term deposit rates elevated for most of FY25.

• CASA mix dropped across the board; SA rate cuts initiated (e.g., ICICI, Kotak).

• Repo-linked loans reprice faster than deposits — compressing spreads.

📈 Fee Income: Bright Spot

• All banks saw strong growth in non-interest income:

  • Axis: +20% YoY in fees, led by cards, wealth, payments.

  • ICICI: Fee income +16% YoY in Q4.

  • Federal: Fee income outpaced loan growth.

  • Kotak: Capital markets, wealth, and insurance distribution drove growth.

  • IDFC First: Improving momentum in fee lines post tech scale-up.

🛠 Cost Control & Operating Leverage

• Axis: Opex growth moderated from 30% to 6% YoY.

• ICICI: Best-in-class cost ratios, benefit of digital maturity.

• HDFC Bank: Tight leash on costs; tech investments expected to show results in FY26.

• IDFC First: Opex to asset ratio improving sequentially.

• Federal: Focused on productivity via “12 themes” strategy.

• Kotak: Restructured org to cut overlaps, focus on unit economics.

📌 Outlook FY26

• Margins likely to compress gradually with rate cuts.

• Fee income and cost efficiency will be critical to defend RoA/ROE.

• Banks will lean more on digital, analytics, and bundling to drive profitability.

6. Deposit Dynamics & Liability Strategy

💸 Deposit Growth Outpaced Credit at Most Banks

• HDFC Bank: Prioritized deposits to normalize CD ratio (from 110% to 96%).

• Axis, ICICI, Kotak: Steady double-digit deposit growth (~11–14%).

• YES Bank, IDFC First: Focused on rebuilding deposit franchise and reducing reliance on bulk.

📉 CASA Ratios Under Pressure

• Broad trend of declining CASA share across banks:

  • HDFC Bank: CASA at 38.4% (down YoY).

  • Axis and ICICI: CASA growth slower than term deposits.

  • Kotak: CASA dipped; shift toward higher-yielding TDs.

  • Federal: CA growth strong, but SA saw some rate pressure.

🏦 Term Deposits Became the Anchor

• Most banks leaned heavily on retail term deposits.

• High interest rates during liquidity squeeze (mid-FY25) drove TD preference.

• Aggressive pricing by smaller banks and PSBs intensified deposit competition.

💼 Strategic Shifts in Liability Franchise

• Kotak: Sharpened focus on affluent and premium segments for sticky deposits.

• Federal: Emphasizing bundled deposit products (ActivMoney, flexible sweep).

• ICICI: Continued leveraging 360° customer view to deepen liability wallet share.

• YES Bank: Reduced RIDF deposits (from 11% to 8.7% of liabilities).

• IDFC First: Cut SA rates to reduce cost; focused on mass-retail mobilization.

🔄 Rate Actions and Repricing Discipline

• SA rate cuts initiated by ICICI, Kotak, Axis — ahead of expected repo rate reductions.

• Most banks refrained from overpaying for non-retail or institutional deposits.

• Spread management prioritized over volume in pricing decisions.

📌 Outlook FY26

• Liquidity likely to ease further — reducing deposit cost pressure.

• Banks will aim to improve CASA through digital CX, bundled accounts, and RM-driven acquisition.

• Liability strategy will focus on cost, duration mix, and customer stickiness.

7. The Unfolding MFI Reset

⚠️ MFI Lending Under Heavy Stress

• IDFC First:

  • MFI GNPA elevated; SMA 1 & 2 in MFI book at 5.1%.

  • Collection efficiency dipped mid-year; partially recovered in Q4.

  • Credit cost excluding MFI: 1.76% vs 2.46% overall.

  • Bank paused fresh originations in high-risk geographies.

• Kotak Mahindra Bank:

  • MFI portfolio shrunk by 33% YoY.

  • Management called out “structural issues” and “intense competition with lax pricing.”

  • Actively reassessing business model.

• Federal Bank:

  • Marginal MFI stress noted; not material to balance sheet.

  • More selective on sourcing, leveraging data analytics for underwriting.

• YES Bank:

  • Avoiding fresh MFI lending unless a platform-level acquisition opportunity arises.

  • Focused on retail MSME and secured lending instead.

📉 Profitability Drag

• MFI credit costs significantly elevated, pulling down ROA for IDFC First and Kotak.

• High operational intensity + small-ticket + vulnerability to local disruptions = weaker unit economics.

🧠 Structural Re-evaluation Underway

• Lending model under scrutiny:

  • Shift from JLG to individual lending gaining traction.

  • Some banks evaluating agent-led vs branch-led models.

  • Increased use of credit bureau data and psychometric risk scoring.

• Pricing discipline and geographic de-risking are new priorities.

📌 Outlook FY26

• MFI will remain a stress pocket despite tactical recovery signs.

• Banks may rebuild exposure slowly, with tighter cohort definitions and tech underwriting.

• Consolidation likely: larger NBFC-MFIs or fintechs could be acquisition targets.

8. Digital, Distribution & Strategic Realignment

🏦 Branch Expansion Remains Active

• Axis Bank: Added ~500 branches in FY25, now at 5,385.

• ICICI Bank: Added 460 branches; total network ~6,983 branches.

• HDFC Bank: Continued rural and semi-urban expansion to support deposit growth.

• YES Bank: Focused on selective expansion in priority segments.

📱 Digital Channels Gaining Strategic Importance

• Kotak:

  • Major app upgrade across customer segments.

  • Brand unification under “One Kotak”; enhanced UI for affluent (Solitaire), youth (811), and merchants.

• Federal Bank:

  • “Operation Udaan”: revamp of mobile, net banking, and RM tools.

  • New digital journeys launched for gold loans, CV/CE, and LAP.

• ICICI Bank:

  • Focused on straight-through processing (STP) and embedded finance.

  • Continued investments in system resilience and simplicity.

• IDFC First:

  • Digital cross-sell and engagement driving fee growth.

  • Using behavioral models to drive product adoption.

🔄 Strategic Realignments in Operating Models

• HDFC Bank:

  • Reorganized entire asset side under unified leadership.

  • Integrated rural/agri, gold, auto loans to drive cross-product synergies.

  • Aimed at enhancing staff productivity and customer engagement frequency.

• Kotak:

  • Shifted from product-push to customer-centric approach.

  • Segmented teams with scorecard-linked accountability (RoA-focused).

• Axis:

  • Executing “GPS” strategy (Growth, Profitability, Sustainability) with focus on profitable customer cohorts.

  • Strengthening tech stack to support omni-channel delivery.

🎯 Productivity & Profitability Focus

• Banks are linking RM KPIs to customer value and profitability, not volume.

• Digital servicing + assisted journeys are replacing branch-only sales.

• Use of data for customer lifecycle value (CLV) analytics expanding across the board.

📌 Outlook FY26

• Digital maturity will increasingly differentiate operating efficiency.

• Banks will aim for full-stack delivery: digital origin, physical support, smart engagement.

• Strategic clarity on customer segments, unit economics, and channel ROI will shape competitive edge.

9. Capital Strength & Resilience

🧱 Well-Capitalized Balance Sheets Across the Board

• ICICI Bank:

  • CET-1 at 15.94%, Total CAR at 16.55% (post dividend).

  • Among the most conservatively capitalized in the industry.

• HDFC Bank:

  • Maintains robust capital buffers; gradual CD ratio normalization to free up lending capacity.

  • No immediate capital raise; internal accruals sufficient.

• Axis Bank:

  • CET-1 at 13.8%, Total CAR at 17.69%.

  • Comfortable to fund organic and ecosystem-led growth.

• Kotak Bank:

  • CET-1 above 17%; among highest in industry.

  • Can absorb shocks, invest in digital, and pursue acquisitions if needed.

• Federal Bank:

  • CET-1 at 14.9%, well above regulatory requirements.

  • Actively managing RWA density to maintain return on equity.

💼 Capital Raising Moves

• IDFC First Bank:

  • Raised ₹7,500 crore from marquee investors (GIC, Carlyle, SBI MF, AIA).

  • Strengthened Tier 1 to fund growth and absorb MFI credit costs.

• YES Bank:

  • Adequate capital after recent clean-up; no immediate fund-raising plans.

  • Enabling approvals in place for AT1 and Tier 2 issuance if needed.

🧮 Use of Capital Buffers

• Axis, ICICI, and Kotak have contingent provisions (non-NPA) to absorb shocks.

• Capital being deployed selectively — based on RoA/return-on-capital lens.

• Minimal use of leverage; focus remains on granular, low-risk expansion.

🔄 Dividend & Shareholder Return Trends

• ICICI: Recommended ₹11/share dividend for FY25.

• Axis: No dividend, reinvesting in growth.

• HDFC Bank: Consistent dividend history; payout backed by strong internal accruals.

• Kotak: Prefers internal capital deployment to boost long-term value.

📌 Outlook FY26

• Most private banks are overcapitalized by design, offering resilience and optionality.

• No dilution risk for major players.

• Strong capital base supports continued investments in tech, growth, and potential M&A plays.

10. Bank-by-Bank Comparative Dashboard

A quick snapshot of key financial and strategic metrics across the 7 major private sector banks:

🧩 Highlights by Theme

🟢 Strongest Performers

• ICICI Bank: Best-in-class across profitability, risk, and capital.

• HDFC Bank: Conservative, stable with focus on synergy realization.

• Axis Bank: Improving margins, fee income, and operating leverage.

🟡 Focused Rebuilders

• Kotak: Realigning around profitability and tech scale-up.

• Federal: Executing focused transformation with rising momentum.

🔴 Watchlist for Execution

• IDFC First: Capitalized, but needs sharp recovery in asset quality.

• YES Bank: Asset cleanup largely done, focus now on growth without slippage.

11. What to Watch in FY26

🔄 Rate Cycle Implications

• RBI expected to cut policy rates further (50–100 bps possible).

• Repo-linked loan repricing will reduce yields faster than deposit costs.

• Margin compression risk is real — especially for retail-heavy and high-NIM banks.

💳 Unsecured Lending Resurgence?

• Personal loans and credit cards may see selective re-acceleration.

• Most banks remain cautious; tighter underwriting and RoA-based pricing frameworks in place.

• Bounce rates and early delinquencies will be key indicators.

🌱 SME and Mid-Market Lending Momentum

• SME/Mid-corporate loan growth remains strong and profitable.

• Banks investing in digital journeys, cash management, and cross-sell to defend spreads.

• Trade finance and working capital revival expected in H2FY26.

🧾 Fee Income as a Growth Lever

• Distribution income (insurance, AMC, wealth) will drive non-interest revenue.

• Transaction banking and payments remain competitive edge for top-tier banks.

• Fee-to-assets ratio expected to rise at Kotak, Federal, Axis.

🧮 Credit Cost Stabilization

• Ex-MFI books show signs of stabilization in retail delinquencies.

• FY26 credit costs expected to normalize to 40–60 bps for most banks.

• Watchlist: unsecured retail, MFI, and SME exposures in specific geographies.

💡 Tech & Digital ROI

• Many banks completed large tech rollouts in FY25.

• FY26 will test whether digital upgrades deliver:

  • Lower opex, higher cross-sell, better onboarding.

  • Improved RM productivity and lead conversions.

🧱 Capital Deployment & Optionality

• Most banks are well capitalized — optionality exists for:

  • Aggressive market share capture.

  • Small strategic acquisitions (e.g., NBFCs, fintechs).

  • Dividend payout or share buybacks in select cases.

📌 Strategic Differentiation Will Intensify

• Kotak, Axis, and Federal are sharpening focus on customer segment economics.

• ICICI and HDFC Bank will double down on ecosystem and distribution leverage.

• YES Bank and IDFC First will focus on execution stability and asset quality rebuild.

12. Conclusion: Strength in Divergence

🧭 FY25 was a year of strategic maturity

• Private banks didn’t chase growth blindly despite strong credit demand.

• Focus shifted toward profitable, risk-adjusted, and capital-efficient lending.

⚖️ Sector outlook is resilient, but uneven

• Large banks (ICICI, HDFC, Axis) are positioned for steady compounding.

• Mid-sized banks (Kotak, Federal) are focused on sharpening execution and segment differentiation.

• Turnaround players (IDFC First, YES) are capitalized but need clean execution.

💼 Margins and credit quality will define leadership

• Rate cuts and liquidity surplus will squeeze NIMs.

• Retail credit quality is stabilizing; corporate books remain clean.

• MFI remains the primary area of concern across the board.

🚀 Three big themes for FY26 and beyond

1. Digital productivity → Better margins, lower opex, deeper cross-sell.

2. Segment-led growth → Profit-focused customer acquisition across retail and SME.

3. Capital discipline → Deployment decisions based on RoA, not just book growth.

🏁 Bottom line:

• India's private sector banks are fundamentally strong, strategically sharper, and digitally deeper.

• As the cycle turns and the margin tailwind fades, the next phase of outperformance will come from execution, cost control, and customer franchise strength — not just loan book expansion.

Don’t like what you are reading? Will do better. Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

Investor Deep Dive Covering the Top 7 Developers

An analysis of the Indian real estate sector based on Q4-25 management commentary from the seven largest listed developers, highlighting the industry’s shift from cyclical swings to strategic, execution-led growth.

• DLF (NSE: DLF)

• Godrej Properties (NSE: GODREJPROP)

• Macrotech Developers / Lodha (NSE: LODHA)

• Oberoi Realty (NSE: OBEROIRLTY)

• Prestige Estates (NSE: PRESTIGE)

• Brigade Enterprises (NSE: BRIGADE)

• Phoenix Mills (NSE: PHOENIXLTD)

1. Sector Snapshot: A Year That Recast the Real Estate Playbook

FY25 marked a shift from momentum-driven optimism to disciplined execution across India's top developers. Management commentary across earnings calls reflects a sector that has matured — financially, operationally, and strategically.

✅ Record Presales Across the Board

• DLF: ₹21,000+ Cr sales — their highest ever

• Godrej: ₹29,444 Cr (+31% YoY), largest among listed peers

• Lodha: ₹17,600 Cr, with five ₹4,000 Cr+ quarters

• Prestige: ₹6,957 Cr in Q4; full-year guided ₹24,000 Cr

• Oberoi: Strong FY25 on 2× YoY booking growth

• Brigade: Highest-ever presales; 54% from new launches

• Phoenix Mills: Retail consumption at ₹13,750 Cr (+21% YoY)

✅ Margins & Cash Flow Prioritized Over Scale

• EBITDA margins held ~30–35%

• DLF posted ₹6,200 Cr in operating cash surplus

• Brigade (+36% OCF YoY), Godrej (+73%), Lodha and Oberoi saw cash-led earnings growth

✅ Balance Sheets Stronger Than Ever

• DLF net debt nearly wiped out in residential

• Lodha (0.2x net D/E), Godrej near zero

• Developers funding expansion from cash, not leverage

✅ Annuity Income Matures into Core Portfolio Pillar

• Phoenix: ₹1,951 Cr rental income (+18% YoY)

• DLF: ₹6,700 Cr annual rental target by FY26

• Oberoi, Brigade, and Prestige expanding Grade A retail/office exposure

🔍 Investor Lens
Valuation upside now hinges on margin durability, cash conversion, and execution—not sales hype.

2. Demand: Depth, Not Just Direction

Developers reported not just higher bookings — but more sustainable conversions, across geographies and price points.

✅ Booking Velocity Was Healthy and Sticky

• Godrej: ~50% of bookings outside Mumbai

• DLF: Sold out multiple Gurgaon and Privana phases pre-launch

• Oberoi: EOIs exceeding supply in Borivali, Adarsh Nagar launches

📍 Geographic Expansion Is Smart, Not Scattershot

• Lodha: Deeper into Pune, Upper Thane, South Mumbai

• Brigade: Expanding in Chennai and Hyderabad

• DLF: Multi-city with launches in Goa, Mumbai, Gurgaon, Taramani

🏗 Launch Visibility Anchored FY26 Guidance

• Godrej: ₹40,000 Cr in launches

• DLF: ₹17,000 Cr guided, including premium projects

• Oberoi, Prestige, and Brigade planning phased execution in H2

🔍 Investor Lens
Focus on developers with phased launch strategies and stable conversion metrics.
➡️ DLF, Oberoi, and Lodha stand out with >8% conversion efficiency.

3. Profitability: Margins Built to Last

✅ Gross & EBITDA Margins Held Strong

• DLF: ~30%+ residential EBITDA margin; 10.2% ROE

• Oberoi: ~50% margins on premium inventory

• Lodha: ~33% even with higher JDA share

• Godrej, Brigade: Margin expansion via premiumization

🧾 Land Strategy Reflects Capital Discipline

• JDAs deployed selectively: Lodha, Godrej, Prestige

• DLF and Oberoi use owned land for margin-rich launches

• Phoenix expanding via densification in High Street Phoenix, Hebbal

🔁 Cash-Led Execution Is the Norm Now

• Godrej and Brigade led in OCF-to-revenue growth

• DLF’s surplus allows FY26 project scaling without leverage

• Phoenix and Oberoi moving to platform-led monetization

🔍 Investor Lens
Don’t just screen on EBITDA — track cash-backed earnings and ROCE trends to isolate real performers.

4. Commercial & Retail: Core Earnings, Not Optional Upside

This is where annuity value is now real — and rising.

✅ DLF Scaling Grade-A Rentals

• ₹6,700 Cr rental exit income guided by FY26

• 4.6M sq. ft. office + 1.4M sq. ft. retail under delivery

• Vacancy <6%; rental losses just 4% of potential

✅ Phoenix Mills Retains Leadership

• Retail rental: ₹1,951 Cr; EBITDA: ₹2,161 Cr

• Office leasing in Pune, Chennai, Bangalore ramping up

• Revenue-share models gaining adoption

✅ Oberoi, Brigade, Prestige Building Rental Base

• Oberoi’s Sky City Mall gaining organic brand traction

• Brigade and Prestige malls reported 80–90% occupancy

• DLF Downtown Gurgaon and Chennai (Taramani) to drive multi-phase scale

🔍 Investor Lens
Retail + commercial monetization is now trackable by:

• Exit rentals

• Pre-leasing velocity

• Tenant retention quality
  ➡️ DLF, Phoenix, and Oberoi are leaders on asset stability and yield potential.

5. Risk Radar: Granular, Not Generic

⚠️ City-Level Bottlenecks

• Approval delays in Bangalore and Hyderabad (Brigade, Prestige)

• Fit-out lag in Phoenix and Oberoi delaying full rental absorption

⚠️ Micro-Market Oversupply

• Hyderabad flagged for 9 quarters of unsold inventory

• New launches calibrated unless pre-commitments are strong

⚠️ Inflation Watch

• Cement and labor costs stable, but FY26 H2 may see cost creep

⚠️ Execution Bandwidth

• DLF, Lodha and Prestige have multi-site launches; execution timelines need close tracking

🔍 Investor Lens
Stress-test launch-to-cash cycles by city.
➡️ Stick to players with proven speed of approvals, sales-to-collections, and regulatory clearance efficiency.

6. FY26 Playbook: Picking Execution Over Exposure

🎯 What Will Matter Most

• Pre-sold inventory + clear construction timelines

• OCF acceleration without balance sheet bloating

• Rental asset ramp-up: From footfall to EBITDA

📌 Developer Differentiators

• DLF: Institutional-grade governance, annuity growth

• Godrej: National footprint, strong cash cycle

• Lodha: Capital-light scale, high conversion

• Oberoi: Margin supremacy, low debt

• Prestige: Market-share gainer, expanding outside base

• Brigade: Balanced annuity + resi mix

• Phoenix Mills: Retail yield machine, office upside coming

7. Final Word: From Real Estate to Real Compounding

India’s listed developers have structurally evolved.

• Presales are consistent, not cyclical

• Margins are managed by design, not pricing luck

• Retail and office add durability to P&L

• Land strategy is governed by IRR, not speculation

🧩 FY26 will reward developers who combine free cash flow, high-margin execution, and annuity ramp-up — not just those who sell fast.

Bottom Line for Investors:
It’s no longer about “playing the sector.”
It’s about identifying the developers who’ve made real estate an investable business — not just a sales engine.

Don’t like what you are reading? Will do better. Let us know at hi@moneymuscle.in

Don’t miss reading our Disclaimer

1. Impact of Trump’s Reciprocal Tariffs on Indian Pharma Industry

2. Indian Pharma Industry’s Strategic Response to Tariff Risks

3. Hidden Growth Opportunities for Indian Pharma Amid Trade Tensions

4. Winners & Losers in Indian Pharma Post-Tariffs

1. Impact of Trump’s Reciprocal Tariffs on Indian Pharma Industry

1.1 Current Tariff Status: Indian Pharma Temporarily Exempt

• Pharmaceutical products (formulations, APIs) are currently excluded from the 26% tariffs imposed by the U.S. on a wide range of Indian imports.

• However, Trump has previously signaled discomfort with low-cost generics flooding the U.S. market and has pushed for “Buy American” healthcare policies.

• Implication: The exemption may be temporary or politically reversible. Future tariffs, restrictions, or non-tariff actions are very possible.

1.2 U.S. Dependency of Indian Pharma Exports

• The U.S. is the #1 market for Indian generics, with annual exports > $10 billion

• The U.S. accounts for ~30-35% of India’s pharma exports, particularly in generic formulations.

• Leading exporters like Aurobindo, Dr. Reddy’s, Lupin, and Sun Pharma derive a major chunk of revenues from the U.S. generics market.

• Implication: Even indirect disruptions (e.g., lower demand from U.S. buyers or tighter regulation) can significantly affect toplines.

• Risk Level: High for generics-heavy exporters with >35% U.S. share

1.3 Tariffs and Margin Risk in Indian Generic Drugs

• Generic drugs in the U.S. already operate on razor-thin margins due to:

  • Intense price competition

  • Buyer consolidation (e.g., Walgreens, CVS, Cardinal, McKesson)

  • Regulatory costs

• A 10–15% price hit from tariffs could wipe out margins on many low-value generics.

  • Many Indian pharma players won’t be able to pass on cost increases

• Companies with branded generics or specialty drugs (e.g., Sun Pharma’s Taro, Biocon’s biosimilars) are better insulated.

1.4 Regulatory Risk as a Non-Tariff Barrier

Even in the absence of direct tariffs, the U.S. administration may use non-tariff barriers such as:

• Stricter FDA inspections

• Delays in drug approvals

• Increased scrutiny of Indian manufacturing facilities

Implication: Regulatory pressure can serve as a de facto tariff by slowing down business operations and adding compliance costs.

Impacted the most: Companies that rely on single-site filings or have prior FDA warnings (e.g., Lupin, Aurobindo have had issues in past)

1.5 Supply Chain Localization Pressure on Indian Pharma

• U.S. policymakers are pushing for domestic manufacturing of critical drugs and APIs, citing supply chain security and strategic autonomy.

• While Indian companies still dominate the generics market, there's growing U.S. interest in reshoring production.

• Most Indian pharma companies do not have significant U.S. manufacturing bases. A few exceptions:

  • Sun Pharma: Taro Pharma (U.S.)

  • Cipla: Some capacity via acquisition (InvaGen)

  • Dr. Reddy’s: Limited, but exploring local alliances

Implication: Indian pharma faces long-term pressure to localize manufacturing, invest in U.S.-based facilities, or partner with American CDMOs.

1.6 Why Product Mix Will Define Pharma Winners & Losers

• Biocon and Cipla are pivoting toward biosimilars, specialty inhalers, and value-added generics to escape the price war.

• Sun Pharma is investing in dermatology, branded formulations, and specialty assets in the U.S.

• Policy-wise, Indian pharma associations (like IPA, Pharmexcil) are lobbying for continued tariff exemption based on healthcare affordability arguments.

• Signs of proactive adaptation, but not universal across the sector

High Risk:

• Oral solids (tablets/capsules)

• Off-patent, non-differentiated generics

• Low-barrier-to-entry APIs

More Resilient:

• Biosimilars and specialty drugs (e.g., injectables, oncology, respiratory)

• Branded generics

• CDMO/CRAMS services for global innovators

Implication: Firms moving up the value chain will better withstand global trade and regulatory shocks.

1.7 Trade Uncertainty & Impact on Pharma M&A Strategy

• Trade uncertainty makes U.S. acquisition targets more expensive and riskier

• Pharma partnerships with U.S. firms may slow down due to regulatory bottlenecks or nationalistic preference shifts

• Indian companies may need to invest in U.S. facilities to hedge against future barriers

1.8 How Tariff Uncertainty Affects Pharma Valuations

• Even if tariffs don’t materialize immediately, the fear of future barriers creates:

  • P/E multiple compression

  • Reduced foreign fund interest in U.S.-heavy pharma stocks

2. Indian Pharma Industry’s Strategic Response to Tariff Risks

The Indian pharma industry sees the Trump tariffs more as a diplomatic hurdle than a structural threat. They are confident in their competitive moat, cautious about making big reactive changes, and leaning on policy resolution while staying focused on long-term strategy.

2.1 Indian Pharma Sees Tariffs as Temporary, Not Structural

Most managements are not overreacting to the threat of tariffs. The consensus is that:

• Tariffs are temporary and politically driven, not structural.

• Business decisions—like setting up U.S. facilities—should not be reactionary.

"I'm not sure tariffs should dictate what we should be doing as players, because there is a risk that four years later, those tariffs may go away," Cipla Global CEO Umang Vohra

"I don't know how much difference it (tariffs) will make to us... and will not justify relocating our manufacturing," Sun Pharma MD Dilip Shanghvi.

2.2 Why Indian Pharma Remains Confident in Cost Competitiveness

There’s broad confidence that Indian generics will remain competitive, even with a 26% tariff:

• Indian pharma has strong cost advantages and scale.

• Dr. Reddy’s MD G.V. Prasad called out that relocating to the U.S. isn’t viable due to high costs and lack of infrastructure.

2.3 Will Tariffs Be Passed to U.S. Consumers?

Companies like Sun Pharma indicate that additional costs may be passed on, especially in non-competitive segments:

• There's a belief that the U.S. still depends heavily on Indian generics.

• Price increases are inevitable in some areas.

"Ultimately, it (tariff impact) will be passed on to consumers," Sun Pharma MD Dilip Shanghvi.

2.4 Role of Government Diplomacy in Defending Pharma Exports

The industry is collectively banking on government-to-government negotiations:

• The Indian Pharmaceutical Alliance and major companies are coordinating with policymakers.

• There's optimism that pharma will remain exempt or get preferential treatment due to its critical nature.

“I welcome the US government’s decision to exempt Indian pharmaceutical products from tariffs, which underscores the strong bilateral relationship between India and the US, as well as the critical role of the Indian pharmaceutical sector in enhancing public health,” Biocon Chairperson Kiran Mazumdar-Shaw

2.5 No Immediate Shift in Indian Pharma Manufacturing Strategy

Despite U.S. pressure for domestic manufacturing:

• No major company is planning to shift supply chains or build new capacity in the U.S.

• Indian players believe their current base can handle global demand efficiently.

“Building domestic manufacturing capacity to meet these needs will take years of investment, regulatory adjustments, and workforce development. It’s heartening to see our longstanding partnership with the US being recognized—this relationship has fostered an environment where open dialogue can lead to mutual growth.” Sheetal Arora, CEO & Promoter, Mankind Pharma

3. Hidden Growth Opportunities for Indian Pharma Amid Trade Tensions

3.1 India’s Advantage as an Alternative to Chinese API Suppliers

• If U.S. keeps penalizing China (via tariffs, blacklists, or ESG filters), India becomes the default alternative for API sourcing

• Opportunity: Gain share in paracetamol, antibiotics, anti-diabetics, oncology APIs

• Beneficiaries: Divi’s, Laurus Labs, Aarti Drugs, Neuland

3.2 Biosimilars and Specialty Products: The Next Growth Engine

• U.S. biotech and specialty pharma companies need cost-effective, trusted partners

• India’s contract development & manufacturing sector (CRAMS/CDMO) is gaining traction fast

• Opportunity: Long-term, high-margin partnerships

• Beneficiaries: Syngene, Suven, Gland Pharma, Laurus

3.3 Growth in Biosimilars and Specialty Products

• U.S. needs cost-efficient alternatives to biologics — but manufacturing and regulatory costs are high domestically

• Indian firms with biosimilar pipelines can break into high-value, low-competition markets

• Beneficiaries: Biocon Biologics, Dr. Reddy’s, Zydus Lifesciences

3.4 Nearshoring Manufacturing Hubs

• These can serve U.S. buyers tariff-free and reduce geopolitical friction

• Beneficiaries: Companies with capital flexibility and global compliance systems

3.5 PLI Scheme Driving Domestic Pharma Capex

• India’s Production Linked Incentive (PLI) scheme is driving capex in:

  • Key APIs

  • Complex generics

  • Domestic manufacturing

• Beneficiaries: Mid-tier players upgrading capabilities, especially in API backward integration

4. Winners & Losers in Indian Pharma Post-Tariffs

4.1 Winners: Specialty Drug Makers and Biosimilar Leaders

Why: These products are higher-margin, harder to commoditize, and less price-sensitive. U.S. payers and hospitals need them.

Traits:

• Strong U.S. pipeline of inhalers, injectables, oncology, dermatology, etc.

• Not reliant on high-volume, low-margin generics

• Diversifying toward Europe and emerging markets

Examples (by model, not recommendation):

• Biosimilar-focused: Biocon Biologics

• Specialty-focused: Sun Pharma (via Taro, dermatology)

• Respiratory play: Cipla (inhalers, complex generics)

4.2 Winners: Diversified Pharma Companies with Low U.S. Exposure

Why: Less exposed to direct or indirect policy shocks

Traits:

• U.S. share <30% of total revenue

• Balanced presence in EU, Africa, India, and RoW

• Manufacturing flexibility outside India

Examples (by model):

• Domestic-heavy: Torrent Pharma

• Well-diversified: Cipla, Biocon

4.3 Winners: IP-Driven and R&D-Led Pharma Players

Why: Tariffs and pricing pressure hurt commodity businesses, not IP-led ones

Traits:

• Strong R&D pipelines

• Differentiated delivery platforms (e.g., nano-formulations, fixed-dose combos)

• Partnerships with MNCs or U.S. healthcare systems

Examples (by model):

• Niche R&D players: Syngene, Laurus (CDMO)

• Global partnerships: Glenmark (with partners in EU/US)

4.4 Losers: Generics-Heavy, U.S.-Dependent Pharma Exporters

Why: Tariff hikes, buyer consolidation, and FDA risks hit this model hardest

Traits:

• 40–50% of revenue from U.S.

• Portfolio dominated by oral solids and commoditized generics

• History of FDA compliance issues

Risk Example (by model):

• Aurobindo, Lupin, and other generics-heavy exporters

4.5 Losers: Pharma Firms with FDA or Compliance Challenges

Why: Trump-era FDA could be used as a non-tariff weapon (e.g., increased inspections, warning letters)

Traits:

• Plants with ongoing or unresolved warning letters/import alerts

• Heavy reliance on 1–2 FDA-approved sites

• Reactive instead of proactive compliance

Implication: Disproportionate scrutiny, approval delays, and export disruption

4.6 Losers: Companies Without Innovation or Market Diversification

Why: Tariffs + price pressure + regulatory fog = death spiral for me-too generic companies

Traits:

• No differentiated products or platforms

• Poor visibility outside U.S. market

• No strategic shift toward complex generics or branded exports

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

1. How Trump’s Reciprocal Tariffs Threaten Indian IT Services

2. AI: The Secret Weapon Helping Indian IT Beat the Tariff Fallout

3. Hidden Risks Indian IT Investors Can’t Afford to Ignore

4. The Real Winners and Losers in Indian IT Post-Tariffs

1. How Trump’s Reciprocal Tariffs Threaten Indian IT Services (Infosys, TCS, Wipro, HCL, Tech Mahindra etc. )

Indian IT firms won’t feel the first-order tariff hit, but the second-order ripple effects could be substantial, especially if U.S. clients enter a cost-cutting mode. Margins may stay intact short term, but growth visibility in FY26 could weaken unless macro sentiment improves.

1.1 No Direct Tariff, But Real Indirect Effects

• Services aren’t tariffed, but Indian IT companies are deeply tied to U.S. corporate clients.

• U.S. clients facing higher import tariffs (especially manufacturers, pharma, retail) may cut IT budgets or delay new tech/digital projects.

• Example: A U.S. retailer hit by tariffs on APIs or packaging may delay a planned planned contract with an Infosys or Wipro.

1.2 Client Discretionary Spending May Shrink

• Many Indian IT firms derive 50–70% of revenue from U.S. clients.

• Tariff-led economic uncertainty, higher operating costs for clients, and potential slowdown in U.S. GDP growth could reduce:

  • New contract awards

  • Expansion of existing projects

  • Digital transformation deals (cloud, AI, data)

Effect: Slower revenue growth in FY26, especially in:

• Retail

• Manufacturing

• Pharma/life sciences

1.3 Hiring Pressure: Reinvigorated “Hire American” Push

Trump’s trade moves are typically aligned with:

• Stricter visa scrutiny (H-1B/L-1)

• Push for onshore/U.S. hiring

IT firms may face:

• Increased compliance costs

• More local hiring mandates

• Risk of higher wage bills in the U.S.

TCS, Infosys, and HCL already have large U.S. workforces (30–40% of U.S. employees), but the cost differential versus India is still material.

1.4 Risk of Regulatory or Political Blowback

• Anti-outsourcing sentiment may gain momentum.

• Contracts with government agencies or sensitive sectors (e.g., defense, infrastructure) could come under scrutiny.

Watch for:

• Negative press or political noise around outsourcing

• Reputational risk in U.S. elections/PR cycles

1.5 Increased Push for Diversification

• Indian IT firms likely to accelerate expansion into:

  • Europe

  • Asia Pacific

  • Latin America

• Also building nearshore delivery centers (e.g., Mexico, Poland, Canada) to de-risk U.S. concentration.

2. AI: The Secret Weapon Helping Indian IT Beat the Tariff Fallout

2.1. AI-Led Demand = Secular Growth Engine

Across sectors, generative AI, machine learning, and automation are driving new demand in:

• Cloud modernization

• Business process transformation

• Customer experience platforms

• Intelligent operations

U.S. companies are investing in AI even as they cut traditional IT spends. This creates a bifurcation:

• Old projects = frozen or delayed

• AI projects = accelerated

2.2. Tariffs = Pressure on Traditional Spend

Trump’s reciprocal tariffs are:

• Raising costs for many U.S. companies (retailers, pharma, manufacturers)

• Increasing macroeconomic uncertainty

• Encouraging conservative IT budgets — except where tech is seen as essential or ROI-positive

That hurts:

• Large infra deals

• ERP migrations

• Non-core digital spending

2.3 AI Seen as Cost-Saving — Not Just Spending

While tariffs increase costs, AI adoption is often a cost-efficiency lever:

• Automate customer support (vs outsourcing)

• Optimize supply chains (tariffed goods become costlier)

• Improve decision-making amid margin pressure

So paradoxically, tariffs may actually accelerate AI spending in sectors hit hardest (like retail, logistics, pharma).

2.4 Indian IT Firms: Dual-Speed Opportunity

Firms like Infosys, TCS, and Wipro are aggressively building out AI CoEs (Centers of Excellence) and partnering with hyperscalers (Microsoft, AWS, Google).

2.5 Implications for Investors

Prioritize firms that:

• Have large AI-focused deal pipelines

• Offer AI + automation + cloud as integrated packages

• Are focused on value-creation, not just headcount-driven billing

Be cautious with firms:

• Over-indexed on low-end BPO

• With weak AI/IP portfolios

• Dependent on U.S. manufacturing/retail clients with tariff pain

2.6 Company Snapshot (AI Readiness vs U.S. Risk)

3. Hidden Risks Indian IT Investors Can’t Afford to Ignore

The headline narrative is that Indian IT services are "safe" from tariffs. That’s technically true — but the sub-surface shifts in procurement behavior, visa strategy, compliance, and political noise could reshape the sector's operating environment in the U.S.

3.1 U.S. Enterprise Procurement Shifts

• Tariffs could accelerate “Buy American” or “Local First” mandates within U.S. enterprise procurement policies — even for services.

• This may not be legally binding, but perception and political optics will matter, especially in regulated industries (healthcare, defense, BFSI).

What to watch:

• Shift toward local consultants and U.S.-based firms (e.g., Accenture, Cognizant, domestic SI players).

• Increasing preference for contracting local delivery centers over India-based delivery, even if costlier.

3.2 Risk of Security/Compliance Barriers

• In a high-tension trade environment, data privacy, cybersecurity, and compliance become geopolitical tools.

• Expect stricter scrutiny over:

  • Cross-border data flows

  • Remote access from offshore teams

  • Use of Indian developers in U.S. critical infrastructure work

This could:

• Slow down project execution

• Increase compliance-related cost of service delivery

• Impact public sector or critical infra contracts (cloud, AI ops, telecom)

3.3 Potential for Unofficial Quotas or Soft Sanctions

• Trump’s policy machine often uses non-transparent tools: targeted audits, immigration slowdowns, or federal contract restrictions.

• Indian IT majors that serve U.S. government or defense-adjacent clients could face soft pushback (delayed approvals, red tape).

• Undiscussed risk: A company might technically qualify for a deal but lose out on "strategic preference" grounds.

3.4 Re-Weaponization of Visa Regime (H-1B / L1)

• While H-1B visa restrictions are not part of the tariff order, they’re closely aligned with Trump’s “America First” agenda.

• Expect:

  • Lower visa approval rates

  • Longer processing times

  • More scrutiny on wage levels and job roles

That means higher blended cost per employee for Indian IT firms operating in the U.S., especially mid-size players with less local bench strength.

3.5 M&A Slowdown Risk in U.S. Market

• Indian IT firms have been acquiring U.S.-based companies (digital agencies, ER&D players, niche cloud firms) to build onshore capabilities.

• Trade tensions and political scrutiny may slow M&A approvals or inflate deal premiums for “safe” assets.

Watch for:

• Drop in U.S. acquisitions announced by Indian firms in next 6–12 months

• Shift to nearshore buys (e.g., Mexico, Canada, Eastern Europe)

3.6 Valuation De-Rating Risk

Even if business fundamentals hold, Indian IT stocks could face:

• Multiple compression due to perceived geopolitical risk

• Global fund flows moving away from emerging market IT/outsourcing plays toward “safe” geographies

This is about sentiment, not numbers. Even high-quality firms could suffer from being “India-based, U.S.-dependent.”

4. The Real Winners and Losers in Indian IT Post-Tariffs

✅ 4.1 AI-First and IP-Led Companies

Why: AI & automation = cost-efficiency for U.S. clients → immune from budget cuts

Traits:

• Strong internal AI tools and platforms (e.g., Infosys’ Topaz, TCS’ Cognix)

• Partnerships with Microsoft, AWS, Google Cloud

• Dedicated AI/ML delivery units

Examples:

• Infosys (Topaz, strong AI GTM)

• TCS (AI + cloud convergence at scale)

• Persistent Systems (IP-led, BFSI + healthcare focused)

✅ 4.2 Well-Diversified Geographically

Why: U.S. pressure? Offset by Europe, APAC, Middle East

Traits:

• <60% revenue from the U.S.

• Recent deal wins in Europe, Australia, Japan, etc.

Examples:

• Tech Mahindra (telecom + Europe-heavy)

• LTIMindtree (growing Europe pipeline)

• TCS (broadest international footprint)

✅ 4.3 High Onshore/Local Hiring Readiness

Why: Reduces exposure to H-1B visa tightening and optics of “outsourcing”

Traits:

• 30% of U.S. headcount is local

• U.S. delivery centers or acquisitions

• Experience with U.S. federal/state clients

Examples:

• Infosys (multiple U.S. hubs + large local talent pool)

• Cognizant (technically U.S.-based but India delivery)

• Wipro (investing in U.S. digital studios + acquisitions)

❌ 4.4 Mid-Tier Firms Overexposed to the U.S.

Why: No buffer if discretionary spend drops or clients delay projects

Traits:

• 70% revenue from U.S.

• Low visibility in other markets

• High client concentration

Examples:

• U.S. BFSI exposure is high

• Vulnerable to retail/mid-market

• Heavily reliant on few verticals

❌ 4.5 Body-Shopping / Low IP Firms

Why: Trump policy and enterprise procurement may turn hostile to headcount-based, low-value offshore deals

Traits:

• Low-margin, people-heavy delivery

• Lack of automation/IP to defend pricing

• No distinct value proposition beyond cost arbitrage

Examples:

• Small IT staffing/contracting players

• Tier-3 firms with <₹1,000cr revenue and no platform strategy

❌ 4.6 Heavily Dependent on BPO / Voice Work

Why: These services are easy political targets and vulnerable to automation

Traits:

• Voice-based customer support, collections, back-office ops

• No move toward AI or intelligent automation

• U.S. clients in telecom, retail, or consumer finance

Examples:

• Voice-heavy BPO, healthcare/finance exposure

• Any legacy BPO without AI/analytics evolution

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

1. Emerging Trends & Challenges

1.1 Robust Demand Driven by Weddings & Festivals

• All companies reported strong double-digit growth, largely powered by wedding and festive buying.

• The Indian wedding market, projected at ₹10 lakh crore by 2025, remains a huge demand driver.

1.2 Rising Gold Prices Not Deterring Customers

• Despite a sharp 25%-30% YoY increase in gold prices, demand remains strong.

• Consumers now pause briefly during price spikes but return quickly, especially for wedding-related purchases.

1.3 Shift Toward 18K, Rose Gold & Diamond Jewellery

• Younger buyers are driving demand for trendy jewellery, including 18K, rose gold, and studded jewellery.

• Companies are tailoring collections toward this evolving preference.

1.4 Tier 2/3 Cities Fuel Expansion

• Retail expansion is focused on Tier 2 and Tier 3 cities, where consumer aspirations and gold affinity remain high.

• Players like D.P. Abhushan, Kalyan, and Thangamayil are growing aggressively in these regions using both COCO and FOCO models.

1.5 Omnichannel Growth & Digital Integration

• Online channels (like Candere, CaratLane) are gaining traction, especially among younger audiences.

• CRM tools and loyalty programs are helping brands drive personalized engagement and repeat purchases.

1.6 Organized Sector Gaining Share

• Due to hallmarking mandates and rising compliance costs, consumers are migrating from unorganized to organized players.

• Organized players are expected to reach 50% market share by FY29.

1.7 Margin Pressures from Gold Price Surge

• The rising gold-to-diamond cost ratio is diluting gross margins, especially in studded jewellery.

• Studded margins are under stress due to the increased weight of gold relative to diamonds.

1.8 Competitive Intensity in Regional Markets

• Intense price wars, especially in southern India and Tier 2/3 towns.

• Regional players are becoming more aggressive with local digital marketing and promotional pricing, forcing national brands to increase spending.

1.9 EBITDA Margin Compression in FOCO Expansion

• FOCO (franchise-owned, company-operated) models are lowering EBITDA margins, though PBT margins improve due to lower capital expenditure.

1.10 Global Volatility and Regulatory Risk

• Uncertainty around US tariffs, volatility in gold lease rates, and customs duty changes are creating cost unpredictability.

• Companies are reviewing their hedging strategies to remain insulated from these shocks.

1.11 Lab-Grown Diamonds (LGDs) Still a Niche Threat

• LGDs are impacting the solitaire segment, but this currently forms a small portion of revenue (~1%-3%) for most players.

• Players like Titan and Kalyan are watching this space, but not materially affected yet.

1.12 Inventory Valuation & Hedging Complexities

• Players like D.P. Abhushan highlighted risks related to inventory accounting methods and market vs. book price mismatches during volatility.

• Proper hedging (via GML or futures) is becoming more critical.

2. Demand Outlook

2.1 Short to Medium-Term

• Strong Wedding Pipeline to Sustain Momentum

  • Wedding jewellery continues to be the biggest growth engine, with brands optimistic about ongoing wedding demand in Q4 and beyond.

  • Titan, Kalyan, and D.P. Abhushan are all expecting to end FY25 strongly, driven by wedding-related purchases.

• Consumers Adapting to High Gold Prices

  • Gold prices have jumped ~25% YoY, but customers are more accustomed to volatility now.

  • Brief pauses in buying are followed by quick recovery—especially for weddings, where purchases cannot be delayed for long.

  • Non-wedding demand is more sensitive, but brands note resilience, especially in metros and younger cohorts.

• Consistent Festive & Occasion-led Demand

  • Tier 2/3 markets remain robust, with jewellery tied to regional festivals and life events.

  • Jewellery is still seen as a preferred store of value, especially amid global uncertainty.

2.2 Medium to Long-Term (FY26–FY29)

• Organized Retail to Capture Market Share

  • The organized segment is projected to reach 50%+ market share by FY29, up from ~35%-40% today.

  • This shift will be driven by hallmarking mandates, better designs, and rising trust in national brands.

• Younger Consumers Driving Growth

  • Brands are bullish on demand from millennials and Gen Z buyers, who are driving growth in:

    • 18K, rose gold, and white gold

    • Stones/studded jewellery

    • Everyday lightweight jewellery

  • Titan and CaratLane are betting on this through personalized offerings and omnichannel access.

• Structural Drivers Remain Intact

  • India’s rising disposable income, urbanization, and financial inclusion continue to expand the buyer base.

  • Jewellery remains a multi-generational, culturally rooted category, and gold retains emotional + financial appeal.

2.3 Overall Sentiment

• Titan: Sees steady long-term demand, driven by premiumization and deeper customer engagement.

• Kalyan: Confident about strong wedding pipeline, continued showroom expansion.

• D.P. Abhushan: Expects 20-25% growth next year, led by expansion into new states and formats.

• Senco: Optimistic outlook based on urban/rural traction and wedding/festival visibility.

• Thangamayil: Predicts solid performance from Tier 2/3 growth and gold-as-investment sentiment.

“Despite volatility in prices, consumer appetite for jewellery—especially wedding and investment gold—remains rock solid. The demand curve might wobble, but it's still climbing.”

3. Jewellery Pricing Outlook – 2025 and Beyond

“Brands will protect premium pricing, but tactically bend where they must. With volatility in gold and studded margins, smart pricing – not just competitive pricing – will define the winners.”

3.1 Gold Price Volatility – A Double-Edged Sword

• Gold prices surged ~25–30% YoY, leading to higher ticket sizes but also margin pressure, especially in studded jewellery.

• Management across all companies noted volatility will likely continue due to:

  • Global economic uncertainties

  • Anticipated US tariffs

  • Currency fluctuations (USD strength)

  • Central bank buying

• Most expect prices to remain elevated or range-bound in FY26.

Outlook: High gold prices are the new normal, with occasional sharp spikes. Brands are adjusting product strategy to manage.

3.2 Gross Margin Headwinds – Especially in Studded Jewellery

• Titan and Kalyan noted that rising gold prices dilute margins on studded jewellery since gold makes up a larger share of product cost but earns lower margin than diamonds.

• Margins in studded products (especially above ₹1 lakh) may remain under pressure unless gold stabilizes.

Outlook: Gross contribution (GC) in studded jewellery may stay flat or dip slightly until gold stabilizes.

3.3 Making Charges – Tactical Flexibility Across Markets

• Brands use differentiated making charges to compete in local markets:

  • Stable for staple designs

  • Higher for designer/exclusive pieces

• Kalyan and D.P. Abhushan emphasized that making charges are tactically adjusted based on local competition and product positioning.

Outlook: Making charges will remain dynamic – a key lever for margin optimization and competitive pricing.

3.4 Pricing Discipline in Organized Sector

• Despite regional price wars, large players maintain a premium over local jewelers due to:

  • Branding and trust

  • Design quality

  • Customer service and loyalty programs

• Titan, in particular, is clear about not compromising pricing integrity, even in competitive markets.

Outlook: Expect continued premium pricing for national brands, but more aggressive pricing at lower price points or new markets.

3.5 Franchise (FOCO) Model Affecting Pricing Strategy

• As FOCO share rises (especially for Kalyan and D.P. Abhushan), EBITDA margins will compress slightly, though PBT stays healthy.

• Brands may use pricing incentives (discounts, offers, product bundling) to support franchisee sales without affecting net realization.

Outlook: Expect local promotional pricing and flash discounts in FOCO-heavy geographies, but not sustained price cuts.

3.6 Lab-Grown Diamonds – Limited Pricing Impact (For Now)

• LGDs are impacting solitaire pricing (1-carat+), but this segment contributes <3% of revenue for most.

• Studded jewellery using smaller diamonds is not affected yet.

Outlook: No major disruption in pricing from LGDs in the near term, but brands are watching the space.

4. Under-the-radar insights

4.1 Inventory Accounting Methods Skew Margin Comparisons

Normalize inventory accounting when comparing margins across jewellery stocks.

• D.P. Abhushan uses weighted average cost for inventory valuation. This can artificially inflate gross margins during rising gold price environments (since inventory is carried at older, lower prices).

• Many peers use FIFO or mark-to-market. So, comparing gross margin across companies without normalizing for accounting can be misleading.

4.2 Structural Shift in Revenue Mix: Coins and Investment Gold Are Up

• Companies like Titan and D.P. Abhushan reported higher sales of gold coins, signaling:

  • Gold is being increasingly used as a liquid asset or short-term hedge.

  • Younger and newer buyers may be entering via small-ticket investment purchases before graduating to jewellery.

• Jewellery businesses are acting as gold investment platforms—crossover potential with fintech/wealth tech.

4.3 Repeat Buyers & CRM Are Becoming Core Growth Engines

• Titan has over 4 crore customers in its CRM. A large portion of revenue growth is coming from repeat buyers, particularly in high-value studded segments.

• Brands are using CRM data to trigger event-based marketing (e.g. anniversaries, weddings, birthdays) — boosting conversions.

• Jewellery is moving from a “one-time purchase” category to a lifecycle relationship business.

4.4 Product Innovation in Lightweight, Everyday Jewellery

• CaratLane, Mia, and others are seeing growing traction in daily-wear lightweight jewellery, especially among working women and Gen Z.

• These products have higher margins, faster inventory turns, and open up higher repeat purchases than wedding sets.

• Brands with strong lightweight/studded portfolios may deliver better asset turns and customer LTVs.

4.5 Store Productivity Varies Widely — Even in Top Cities

• Example: Titan mentioned that new competitors near their stores (even in metros) are affecting performance. Some stores face underperformance despite being in mature markets, while others in Tier 2 towns are exceeding expectations.

• Expansion success is not linear. Store location, format, and local brand pull are critical.

4.6 Premiumization and Designer Collaborations as Differentiators

• Titan’s Tarun Tahiliani x Rivaah and D.P. Abhushan’s exhibitions like “Jewels of Mewar” show a clear trend:

  • High-income consumers are willing to pay a premium for designer-backed, culturally rich collections.

  • This helps protect margins and fight price wars in crowded markets.

• Designer tie-ups are becoming a key lever for margin defense and aspirational positioning.

5. Investment Opportunity: Indian Jewellery Sector

5.1 Sector Opportunity

• $100B+ TAM: India is the world’s second-largest jewellery market (~$90B+ in size), expected to grow at 8–10% CAGR over the next decade.

• Low Organized Penetration (~35%): Massive formalization tailwind via hallmarking, GST, and digital transformation. Expected to reach 50%+ by FY29.

• Cultural Stickiness: Gold and jewellery are entrenched in weddings, festivals, and investment habits.

• Aspirational Demand: Younger India is embracing branded, modern, designer jewellery (18K, rose gold, diamond).

• Expanding Margins & Scale: Larger players benefit from scale-driven operating leverage, better sourcing, and CRM-driven repeat sales.

5.2 Risk Factors to Monitor

5.3 Investment Checklist

• Consider high-quality players with:

  • Strong brand equity

  • Visible expansion plans

  • Margin improvement levers (product mix, CRM, repeat customers)

  • Asset-light scalability (franchise/FOCO)

• Diversify across formats (wedding-focused, daily wear, diamond-led players).

• Monitor gold prices, wedding trends, and store economics (SSG, breakeven periods, inventory cycles).

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

1. Emerging Trends & Challenges

1.1 Luxury & Premium Hotels Continue to Lead

• Premium brands like Taj, Oberoi, JW Marriott, and Lemon Tree Premier are seeing stronger ARR and RevPAR growth than mid-market hotels.

• Chalet Hotels reported ADRs reaching ₹13,000 and 17% RevPAR growth.

1.2 Capital-Light Expansion Models

• All major hotel chains are pursuing asset-light growth through management/franchise contracts.

  • Lemon Tree: 13 new management/franchise contracts signed this quarter alone.

  • IHCL (Taj) and EIH (Oberoi) are adding dozens of new properties, focusing heavily on management contracts.

1.3 RevPAR-Driven Strategy Over Occupancy Gains

• Occupancy rates are plateauing around 75–80% for most players, with focus shifting to ARR-driven RevPAR growth for profitability.

1.4 Tier 2/3 Cities & Mid-Market Surge Coming

• While metros still lead, Lemon Tree and others forecast mid-scale demand boom as more households move into aspirational consumption brackets.

• Currently, Metro cities outperform leisure hubs like Goa and Bhubaneswar in growth. Hotels in these areas saw only ~2% YoY growth.

1.5 Boom in Weddings, MICE, & F&B Revenue

• F&B and events (especially weddings) are major growth drivers. Taj and Chalet are investing in high-energy venues and banquet facilities.

1.6 Loyalty & Direct Channels Driving Bookings

• Taj's Tata Neu loyalty platform is now a major contributor to revenue. Ginger brand sees 40% revenue from loyalty members.

1.7 Foreign Tourist Arrivals (FTAs) Recovery Still Incomplete

• FTAs remain below pre-COVID levels. Taj and Chalet expect recovery to accelerate once airport infrastructure (e.g. Navi Mumbai airport) improves.

1.8 Rising Competition & Supply in Key Markets

• High-end projects like Fairmont in Mumbai and other new launches are increasing competition in metro markets.

1.9 Capex Pressure from Renovation Cycles

• Many hotel chains are midway through renovation plans (e.g., Lemon Tree renovating 6,000 rooms by FY27), impacting short-term margins.

1.10 Talent Shortage & Operational Costs

• While talent cost pressure is not yet severe, maintaining service quality in expansion and renovation phases is a key concern.

2. Demand Outlook: 2025 and Beyond

2.1 Short-to-Medium Term (FY25–FY26): Very Strong

• Corporate & Business Travel

  • Surging in metro cities like Mumbai, Delhi, Hyderabad, and Bangalore.

  • Driven by increased domestic air travel (+12% YoY), conferences, and resumed international delegations.

  • MICE (Meetings, Incentives, Conferences, Exhibitions) and G20 spillover effects still visible.

“City hotels are running at near full capacity with strong pricing power” — Chalet Hotels
“Occupancy remains above 78%, and ARR continues to rise” — IHCL

• Leisure & Domestic Tourism

  • Consistent demand in tier-1 leisure destinations (Udaipur, Jaipur, Goa), though growth is tapering vs. metros.

  • Weekend getaways, wellness travel, and destination weddings are key contributors.

“Weddings, F&B and leisure travel are key revenue levers, with extended wedding seasons in Q4” — IHCL

• Mid-Scale & Tier 2/3 Growth

  • Rising middle-class spending and improved road/air connectivity fueling demand in emerging cities (e.g., Nagpur, Raipur, Coimbatore).

  • Lemon Tree and Ginger brands expanding rapidly in these regions.

“Demand in tier 2 and 3 cities is growing faster than metros in terms of % growth” — Lemon Tree

• Foreign Tourist Arrivals (FTAs)

  • Still below pre-COVID levels, especially in leisure segments.

  • However, expected to pick up in FY26, aided by:

    • Weak rupee (making India cheaper)

    • Expansion of airports (e.g. Navi Mumbai, Jewar)

    • Return of global events and exhibitions

“International travel to our hotels in Bali and New York has picked up; India still undervalued” — EIH/Oberoi

2.2 Long-Term View (to 2030): Bullish

• GDP growth (~6–7%), urbanization, rising disposable income, and infrastructural development will drive long-term demand.

• Hotel chains are planning aggressively — over 300 hotels are in active pipelines across chains like IHCL, Lemon Tree, and Chalet.

“Hospitality is writing a new narrative for India at 2047” — IHCL CEO Puneet Chhatwal

3. Hotel Room Supply Outlook

3.1 Overall Direction: Moderate Supply Growth

• Supply growth is expected to lag behind demand, creating favorable pricing power for hotels through FY26–27.

• High land and construction costs are slowing new builds.

• Most chains are expanding via asset-light models (management contracts), which take 18–36 months to go live.

• Occupancy and ARR will stay elevated through FY26 due to demand outpacing new supply.

• Tier 2/3 cities will see a bulk of new capacity—mainly by Lemon Tree and Ginger.

• Ultra-premium and metro inventory will grow slower due to high development costs and regulatory approvals.

• Long-term supply will gradually normalize post-FY27, but pricing power will likely remain in favor of hotels for the next 2–3 years.

3.2 Key Data Points from Hotel Chains

• Indian Hotels (Taj, Ginger, etc.)

  • Total pipeline: 123 hotels

  • Signed 55 hotels & opened 20 in April–Dec 2024

  • Target: 25 openings in FY25, 30+ in FY26

  • 80% of pipeline is capital-light

“More than 50% of our entire hotel base is in the pipeline” — IHCL

• Lemon Tree Hotels

  • Pipeline: ~4,000 keys over next 3 years

  • Signed 13 new properties in Q3 alone

  • Renovating 6,000 existing rooms by FY27

  • Focused heavily on tier 2/3 cities

“Key growth will come from franchise & management models, especially in underserved cities” — Lemon Tree

• EIH (Oberoi Group)

  • Expansion pipeline: 19 new properties

    • 13 Oberoi/Trident hotels

    • 3 luxury boats

  • Split: 10 domestic, 9 international

  • Focus on ultra-premium offerings (slow build cycle)

“We are adding across formats—owned, managed, JV—but timelines extend into FY27+” — EIH

• Chalet Hotels

  • Plans to double room capacity from current ~3,000 keys

  • Actively converting land banks (Bangalore, Navi Mumbai)

  • Focused on luxury and business hotels in metro markets

“Expect new capacity to come online by FY26–27, especially near metro airports” — Chalet

• Ventive Hospitality: Small but fast-growing player expanding via resorts and experiential stays with an asset-light model in early stages

4. Pricing & Revenue Outlook

4.1 Pricing Outlook: Sustained Upside in Average Room Rates (ARR)

• High demand + limited supply = continued pricing power.

• All major players indicated confidence in raising rates without losing occupancy.

• “There’s considerable upside in rate—we are still underpriced for the quality we offer.” Oberoi (EIH)

• “We are operating at 78–80% occupancy. Our focus is now ARR-led RevPAR growth.” IHCL (Taj)

• Achieved ADR of ₹13,000+, among the highest in India. Chalet Hotels

• Targeting mid-single to double-digit ARR growth across segments, with premium brands driving pricing upside. Lemon Tree

4.2 Revenue Outlook: Double-Digit Revenue Growth Expected to Continue

• Industry-wide revenue is expected to grow 10–15% annually through FY26.

• Growth drivers:

  • Higher ARRs (especially in metros & Tier 1 leisure)

  • Full recovery of MICE, weddings, and F&B revenue

  • Pipeline openings starting to contribute from FY25 onward

  • Digital & loyalty-led direct booking channels boosting margins

“We expect to deliver strong growth with sustained margins. Q4 to be in line with Q3.” Projecting 15%+ YoY revenue growth IHCL

• Lemon Tree : Forecasts ~25% revenue CAGR over 2–3 years, driven by scale and new room additions

• Chalet Hotels: Strong revenue visibility from:

  • High-end metro properties

  • New hotels near airports (Bangalore, Navi Mumbai)

  • Commercial assets leasing alongside hotels

4.3 Additional Revenue Levers

4.4 Risks to Monitor:

• Macro slowdown (if GDP dips below 6%)

• Delay in FTA (foreign tourist arrival) recovery

• New supply flooding metros post-2027

5. Profitability Outlook

5.1 Drivers of Profitability Growth: High ARR + Stable Occupancy = Strong RevPAR → Flow-through to EBITDA

• Hotels are operating at 70–80% occupancy, so every ARR increase directly lifts EBITDA.

• Most players are okay sacrificing slight occupancy for ARR-led profit growth.

“We are happy to sacrifice occupancy if it improves ARR and flows to the bottom line.” — Oberoi

5.2 Asset-Light Expansion

• Management contracts and franchises require minimal capital and offer high-margin fee income.

• IHCL’s management fees in Q3 grew 32% YoY.

“80% of our pipeline is asset-light—key to sustaining margins.” — IHCL

5.3 Cost Optimization & Tech Efficiency

• Lemon Tree and IHCL have adopted centralized procurement, digital systems, and AI-driven dynamic pricing.

• IHCL operating margins improved 240 bps YoY despite expansion.

5.4 Diversified Revenue Streams (Weddings, F&B, Loyalty)

• Weddings, MICE, and F&B are now profit centers, not just revenue fillers.

• Taj’s Qmin and Chalet’s events business are high-margin.

5.5 Challenges to Profitability

• High Development Costs

  • Land + construction costs make it hard for owned projects to generate strong ROCE.

  • Oberoi is focusing on mixed-use projects in cities to justify capex.

• Renovation Disruptions

  • Many chains are mid-cycle in refurbishments (e.g., Oberoi Grand Kolkata, Lemon Tree’s 6,000 rooms).

  • Short-term EBITDA may be suppressed at some properties.

• Talent & Wage Inflation (Emerging Risk)

  • While stable for now, increased hiring for new properties and quality service at scale may push HR costs up in FY26–27.

Profitability is peaking — and sustainable.
The combination of strong RevPAR growth, operating leverage, asset-light expansion, and premium positioning is expected to drive high-margin performance through FY26.

6. Investment Opportunity

6.1 The Opportunity

India’s hotel sector is entering a golden phase with:

• High demand outpacing supply

• Record ARR and RevPAR growth

• Margin expansion via asset-light models

• Surging non-room revenue (F&B, weddings, MICE)

• Rising middle-class travel & infrastructure push

Well-managed hotel chains (like IHCL, Lemon Tree, Chalet, EIH) are primed to deliver double-digit revenue and PAT growth over the next 2–3 years.

6.2 Risk-Reward Analysis

6.3 Key Upside Catalysts:

• Foreign tourist arrivals return to pre-COVID levels

• Tier 2/3 market expansion accelerates

• Airport hotels + infra projects (e.g., Navi Mumbai) drive localized booms

• Premiumization supports rate hikes without demand drop-off

• Brand-led consolidation takes market share from unorganized players

6.4 Key Risks:

• Macro shocks (geopolitical events, inflation)

• New supply flooding metros post-FY27

• Wage inflation and staffing gaps

• FX volatility if operating abroad

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

1. Key Trends

1.1 Robust Loan Book Growth Across Players

• 20–30% YoY AUM growth, with strong traction in disbursements.

1.2 Shift Towards Affordable and Emerging Segments

• Companies pushing deeper into Tier 2–4 towns, targeting affordable housing and self-employed borrowers.

1.3 Strong Asset Quality Despite Growth

• Gross NPAs mostly held in the 0.3%–1.5% range, and credit costs were largely contained at 15–30 bps, supported by proactive provisioning and early warning systems.

1.4 Healthy Profitability & Operating Leverage

• NIMs remain strong, especially for players in the affordable segment (e.g., Aptus at ~13% NIM, Aavas at ~7.7%).

• Companies are achieving high ROA (2.5–3.5%) and ROE (11–18%) through lean ops and high yield loans.

1.5 Stress in Low-Ticket/Informal Segment (Stage 2 Creep)

• Multiple companies saw marginal increases in Stage 2 assets, attributed to stress in the informal/MFI-exposed customer base, and seasonal/festival delays in collections (especially Q3).

• Expected normalization in Q4.

1.6 Geographic Issues (Karnataka, Andhra, Hyderabad)

• Operational hurdles like registration delays, HYDRAA implementation, E-Khata challenges, and floods in TN impacted disbursements and collections.

1.7 Pressure on Spreads

• New business yields are often lower than existing book, leading to gradual compression in spreads for players like LIC HFC and Bajaj HFC.

1.8 Intensifying Competition

• Pricing competition from banks and large NBFCs is increasing, especially in the prime salaried segment and metro markets.

1.9 BT-Out Risk Remains

• Companies are investing in retention analytics and teams, but balance transfers continue to be a risk. Some players are targeting BT-in and PMAY to counterbalance this trend.

2. Loan Book: Strong Growth

2.1 Strong Growth in Affordable and Tier 2–4 Markets

• Most players are driving growth through:

  • Self-employed and informal segments

  • Expansion in semi-urban and rural geographies

  • Aggressive investment in branch expansion and digital sourcing

2.2 Retail-Focused Players Outperform

• Companies like Aptus, Aavas, and PNB HFL posted strong growth due to exclusive focus on retail secured loans and avoidance of wholesale risk.

2.3 Growth Headwinds for Traditional Players

• LIC HFL’s growth at 6% was the lowest, citing operational issues in Bangalore & Hyderabad (tech issues, HYDRAA), despite a large book.

2.4 PMAY and Government Schemes Provide Tailwinds

• Players expect loan book acceleration in FY26 driven by PMAY 2.0, particularly in affordable housing.

2.5 Cautious Approach in Prime/Metro Segments

• Prime salaried loans and metros are seeing intense competition and yield pressure, limiting growth appetite for some like LIC HFL and Bajaj HFC.

3. Asset Quality: Stable with Uptick in Stage 2 Assets

3.1 Stable to Improving GNPA Across the Board

• Most companies reported either flat or improved GNPA figures compared to previous quarters.

• LIC HFL and Aadhar expect further cleanup in Q4.

3.2 Mild Uptick in Stage 2 Assets

• Marginal increases seen in companies like Aadhar, Aavas, and Aptus — attributed to:

  • Festive season cashflow mismatch

  • Tech/registration disruptions (e.g., HYDRAA in Hyderabad)

  • Some overlap with MFI or informal borrowers

3.3 Strong Collection Efficiency

• Ranges from 98% to 99.5% across the board.

• Even players exposed to informal/self-employed customers maintained <4% 1+ DPD.

3.4 Technical Write-offs Rising (as per policy)

• Aptus and others are following 24-month policy-based technical write-offs, but continue recovery efforts.

• Write-offs are matched by recoveries in several cases, offsetting credit cost impact.

3.5 High Provision Coverage Maintained

• Players like Aptus, PNB HFL, and LIC HFL maintain >80% PCR on Stage 3 assets.

• Several also carry management overlays for cushion.

3.6 Outlook

• Most players expect Q4 to show improvement in asset quality.

• Credit cost guidance is stable at 15–30 bps range.

• Companies are leveraging AI-driven early warning systems and data analytics to monitor risk.

4. Demand: Strong in affordable and underserved markets

4.1 Strong Structural Demand in Affordable Housing

• Demand for housing loans from low- and middle-income (LMI) and informal/self-employed segments remains robust.

• Players like Aptus, Aavas, and PNB HFL are doubling down on Tier 3/4 city penetration.

4.2 Positive Policy Tailwinds

• PMAY 2.0, SWAMIH Fund, and income tax reliefs (₹12L income exemption) are expected to boost housing demand in FY26.

• Several companies mentioned early signs of traction in PMAY-linked applications and disbursements.

4.3 Localized Disruptions, Not Demand Weakness

• Issues in Hyderabad (HYDRAA), Bangalore (registration tech), and Maharashtra (elections) affected Q3 disbursements, but demand remained intact.

• LIC HFL, PNB HFL, and Aptus all expect strong Q4 bounce-back.

4.4 Self-Construction and Small-Ticket Housing Demand

• Self-built homes, small-ticket housing, and first-time buyers are key growth engines.

• Players are tailoring products for <₹15L ticket size, where demand is most resilient.

4.5 Developer Activity Slower, But Buyer Demand Stable

• Bajaj HFC noted lower launches, but good absorption wherever launches happened—no inventory overhang.

• LRD (lease rental discounting) and LAP (loan against property) are also stable in demand.

4.6 Forward Guidance / Growth Targets

• Most companies project:

  • Disbursement growth: 20–30% YoY

  • AUM growth: 20–26% YoY

  • Especially in affordable and near-prime verticals

The consensus across all earnings calls is clear and confident:
Demand for housing loans—especially in affordable and underserved markets—is strong and likely to accelerate further in FY26, supported by structural drivers and positive policy tailwinds

5. Funding & Liquidity Trends: Cost of Funds Stabilizing

5.1 Cost of Funds Stabilizing After Peak

• Cost pressure is easing due to stabilizing interest rates, improved credit ratings, and selective access to concessional sources (like NHB refinance).

5.2 Diversified Borrowing Mix

• Most HFCs are actively diversifying funding sources to reduce reliance on bank loans.

  • Aavas: Raised ₹630 Cr via IFC green bonds – largest ever NCD for the company

  • Aptus: Issued NCDs to mutual funds (₹325 Cr); NHB and IFC also part of funding mix

  • PNB HFL: Secured ₹5,000 Cr NHB line, $350 Mn ECB sanctions

5.3 NHB Refinance: Still Relevant, but Selective

• NHB refinance, especially under the Affordable Housing Fund (AHF), remains a low-cost source (~5.5–7%).

• NHB funds are still valuable, but eligibility is more restrictive, prompting HFCs to build alternate buffers.

  • Aadhar HFC received AHF allocation covering ~25% of its NHB drawdown

  • LIC HFL mentioned that only ~25% of NHB funding qualifies under AHF.

5.4 Liquidity Buffers Remain Healthy

• HFCs are maintaining 10–15% of loan book as liquidity to manage short-term obligations and meet regulatory LCR norms.

• Many companies are now proactively managing liquidity, rather than reacting to market shocks (as seen in COVID era).

5.5 Floating Rate Book Well Matched

• Most players reported a balanced mix of floating-rate liabilities and assets, reducing interest rate mismatch risk.

• Interest rate movements (up or down) are mostly passed through without significant spread volatility.

5.6 Co-Lending & Alternative Funding Channels Emerging

• HFCs like Aavas are exploring co-lending partnerships with PSU banks to expand reach without balance sheet strain.

• ECB routes being tapped more actively by larger players with good credit standing.

6. Challenges Across Segments

6.1 Rise in Stage 2 Assets

• Short-term delays in repayment due to festivals (Diwali, Dussehra), elections, or seasonal cashflow mismatches among informal/self-employed borrowers.

• Impacted Players:

  • Aadhar Housing, Aavas, Aptus, and PNB Housing flagged mild increases in Stage 2 buckets.

  • Mostly in the 30–60 and 60–90 DPD buckets, not full-blown NPAs.

  • Expect normalisation in Q4 with improved recoveries and collection efficiency.

6.2 Localised Disruptions in Disbursements

• Karnataka (E-Khata registration issues)

  • Slowed loan disbursement in urban and semi-urban areas.

• Hyderabad (HYDRAA authority rollout)

  • Property registration & approval delays caused temporary disbursement freeze.

• Bangalore (Tech system glitches)

  • Impaired property registration systems halted ₹600–800 Cr worth of disbursals for players like LIC HFL.

• Andhra & Maharashtra

  • Weather events (floods), election-related administrative slowdowns.

These were temporary issues, but impacted Q3 loan growth for several players like LIC HFL, PNB HFL, and Aptus.

6.3 Competition-Induced Spread Compression

• Banks offering lower rates on prime home loans, leading to:

  • Increased balance transfer (BT) outflow

  • Yield pressure, especially on new originations

• Impacted Players:

  • LIC HFL, Bajaj HFC, and PNB HFL acknowledged that yields on incremental lending are 40–50 bps lower than book yields.

• Strategy Response:

  • Shifting focus to affordable/self-employed segments for better pricing power.

  • Building retention teams and AI-powered early warning systems to manage BT-out.

6.4 Developer Lending Risk (Selective)

• Some companies like Bajaj Housing Finance are growing in developer loans (up 59% YoY), which could expose them to project delays and cyclical stress.

• Management, however, indicated that:

  • Most projects are already launched and cash-flowing.

  • No significant DCCO (Date of Completion for Commercial Operations) extensions were given.

6.5 Operational Risk from Rapid Expansion

• Companies like PNB HFL, Aptus, and Aavas are aggressively expanding into Tier 3/4 towns with 30–50 branch additions.

• Risks:

  • Credit underwriting quality in new markets

  • Staff productivity and control

  • Strain on collection infra in new geographies

Most players are investing in predictive analytics, tech platforms, and training to mitigate these risks.

6.6 Credit Cost Volatility from Technical Write-Offs

• Players like Aptus and PNB HFL reported increased technical write-offs (e.g., loans >24 months in NPA).

• While recoveries from written-off pool are ongoing, it creates optical spikes in credit cost in certain quarters.

6.7 Funding Cost Pressure

• Though stabilising now, funding cost rose during tight liquidity in earlier quarters.

• LIC HFL and Aadhar Housing noted incremental cost of funds of 7.8–8.3%, which impacted spreads.

• NHB refinance rates are rising slightly as AHF (affordable housing fund) allotments are capped.

6.8 Mitigating Factors

• Strong provisioning buffers (e.g., Aptus with 80% PCR, PNB HFL with ₹1,700 Cr write-off pool)

• AI/ML-based early warning systems for collections and BT-out risk

• PMAY 2.0, SWAMIH 2.0, and budget support expected to improve demand and mitigate pressure

7. Conclusion: Positive Outlook with Strategic Adjustments

7.1 Massive Addressable Market

• Long-term structural demand ensures a multi-decade runway for growth

  • Housing shortage of ~25 million units in India, especially in urban low-income segments.

  • Only ~11% of India’s population has access to formal housing finance.

  • Tier 2–4 cities are underpenetrated and represent the next wave of home ownership.

7.2 Strong Government Tailwinds

• Policy support cushions risk and drives volume visibility for lenders.

• PMAY 2.0, income tax reliefs, and infrastructure-led urbanization are directly boosting demand.

• SWAMIH Fund 2.0 supports completion of stalled projects, improving developer viability.

• Push for “Housing for All” is bipartisan and budget-supported.

7.3 Diversification from Traditional Banking Exposure

• Investing in housing finance provides thematic exposure to:

  • Real estate recovery

  • Financial inclusion

  • Urbanization

  • Infrastructure growth

• Ideal for satellite allocation in financial services, distinct from banks or insurance.

7.4 Risk Mitigation Is Strong

• Downside protection, even in economic stress scenarios.

• Conservative LTVs (typically <65%)

• Collateral-backed lending

• Real-time monitoring through tech (AI for collections, risk scoring)

• High provision coverage ratios (>70–80%) and overlays in place

7.5 Industry Consolidation Ahead

• Stricter regulation + capital requirements = exit of weaker players

• Larger, well-capitalized HFCs can gain share organically or via M&A

• Co-lending, fintech tie-ups, and asset-light expansion strategies emerging

• Early entry into platforms that can consolidate the market over the next 5 years.

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

The Quick Service Restaurant (QSR) industry in India has undergone significant transformation, driven by aggressive expansion, intense competition, digital adoption, and shifting consumer preferences. As the sector continues to grow, brands are focusing on value-driven strategies, digital ordering, and delivery efficiency while navigating margin pressures and evolving market dynamics.

Stocks under coverage

Jubilant Foodworks (Domino’s) | NSE:JUBLFOOD | jubilantfoodworks.com

Devyani International (KFC, Pizza Hut, Costa Coffee) | NSE:DEVYANI | dil-rjcorp.com

Westlife Foodworld (McDonanlds) | NSE:WESTLIFE | westlife.co.in

Sapphire Foods India (KFC, Pizza Hut, Taco Bell) | NSE:SAPPHIRE | sapphirefoods.in

Restaurant Brands Asia Ltd (Burger King) | NSE:RBA |  burgerking.in

1. Growth and Market Expansion

Despite weak consumer sentiment, QSR brands are expanding aggressively, betting on long-term growth and urbanization-driven demand. Brands are focusing on:

• Tier-2 & Tier-3 City Penetration: Domino’s, KFC, and McDonald's are expanding into smaller cities where QSR penetration is lower.

• Metro Densification: High-street locations, malls, and business districts remain key for premium positioning.

• Digital-First Store Models: Self-ordering kiosks, AI-driven order personalization, and drive-thru formats are gaining popularity.

QSR Store Expansion (Q3 FY25)

While store expansion remains aggressive, margin pressures and operational efficiency are critical to sustain profitability.

2. Competitive Intensity and Value Proposition

The Indian QSR landscape is witnessing a battle for consumer loyalty, driven by price wars, menu innovations, and tech-driven engagement.

A. Price Wars & Affordable Meals

• McDonald's McSaver Meals: Budget meal bundles targeting value-conscious consumers.

• KFC & Pizza Hut Epic Savers: Tiered pricing for individual and family combos.

• Domino’s Free Delivery Strategy: Removing delivery fees to encourage direct orders.

B. Premiumization & Innovation

• McDonald's McCrispy Range competes with KFC's fried chicken.

• Domino’s Cheese Burst & Chicken Feast drive high-ticket purchases.

• Popeyes Chicken Sandwich & Wings challenge KFC’s dominance in metros.

C. Digital Transformation & Personalization

• 70%+ of orders are now digital, with brands investing in app-based exclusive deals & AI-driven recommendations.

• Self-order kiosks & QR-based table ordering improve customer convenience.

With increased promotional spending and aggressive pricing, brands must balance growth with profitability.

3. The Rise of Delivery and Aggregators

A. The Dominance of Delivery

• 40-70% of revenue now comes from delivery, making it the fastest-growing QSR segment.

• Domino’s delivery orders grew 24.7% YoY, with a focus on 20-minute delivery.

• McDonald's and KFC see 42-50% of revenue from online orders.

B. Aggregators vs. Direct Ordering

QSR brands rely on Swiggy & Zomato for reach but face high commissions (20-30%).

• Domino’s removed delivery fees, pushing users toward its own app for profitability.

• McDonald's & KFC offer app-exclusive discounts to reduce aggregator dependency.

• Popeyes is integrating direct delivery for better control over margins.

C. Future of Delivery

• AI-driven logistics: Optimizing routes & reducing wait times.

• Hybrid model: Maintaining both aggregator partnerships and in-house ordering platforms.

• Increased competition: With Domino’s 20-minute delivery model, aggregators must improve fulfillment speed.

Brands that balance aggregator reliance with direct ordering will gain a long-term competitive advantage.

4. Financial Performance & Profitability Pressures

A. Revenue Growth Across QSR Players

B. Margin Pressures Due to:

• High input costs: Chicken, dairy, and coffee prices have surged.

• Rising operational costs: Real estate & labor expenses remain high.

• Promotional spending & discounts: Higher value-driven campaigns have eroded profitability.

Key Takeaway: While revenue growth remains strong, margins are under pressure due to food inflation and discounting strategies.

5. Future Outlook and Industry Trends

A. Opportunities for Growth

• Tier-2 & Tier-3 Expansion: Rising disposable income & urbanization.

• Tech-Driven Ordering: AI-powered recommendations & dynamic pricing models.

• Loyalty Programs & Personalization: McDonald's & Domino’s lead in digital engagement.

B. Challenges & Risks

• Profitability vs. Expansion: High store openings but delayed breakeven timelines.

• Aggregator Dependency: Brands need to reduce reliance on Swiggy/Zomato for margins.

• Inflation Impact: Rising commodity costs may force menu price hikes.

Conclusion: Who Will Win in the Indian QSR Battle?

The Indian QSR industry is at a crucial inflection point. Brands that focus on:

1️⃣ Balancing affordability with premiumization
2️⃣ Optimizing delivery & reducing aggregator reliance
3️⃣ Leveraging AI-driven ordering & personalization
4️⃣ Improving unit economics & profitability

… will emerge as winners in India’s fast-growing $10 billion QSR market.

Disclaimer

Content Accuracy and Reliability: This information is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities.

Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions.

No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary.

Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional.

Table of Contents

1. Performance Summary: Company-wise Insights

2. Demand: Moderating, but with Growth Pockets

3. Inventory: Lean and Well-Managed

4. Pricing: Disciplined & Selective Increases

5. Product Mix : Focus on Profitability & Growth

6. Conclusion: Emerging Themes for FY26

1. Performance Summary: Company-wise Insights

Insights generated from the management commentary in the Q3-25 earnings call of the companies listed above

2. Demand: Moderating, but with Growth Pockets

2.1 Moderation in Passenger Vehicle (PV) Growth

• After 2-3 years of high growth, PV demand is now expected to grow in low single digits (3-5%) in FY26.

• Rural markets continue to outperform urban demand, supported by good monsoons, rising MSP, and stable farm incomes.

• Urban markets, particularly small cars and hatchbacks, remain under pressure due to subdued affordability and high competition.

• SUV and premium segments continue to lead demand, helping companies sustain market share and profitability.

2.2 Commercial Vehicles (CV): Stable to Moderate Growth

• Bus and passenger carrier segments are performing strongly with double-digit growth.

• M&HCV volumes expected to stabilize and improve in Q4 FY25, driven by infra spending and freight demand.

• SCV segment remains under pressure but efforts are underway to revive it through new product launches and multi-fuel options.

2.3 Farm Equipment (Tractors): Bullish Outlook

• Strong Q4 expected with >15% growth, led by good reservoir levels, strong Rabi sowing, and higher farm incomes.

• Full-year FY25 tractor growth estimated at ~7%, with positive sentiment continuing into FY26.

3. Inventory: Lean and Well-Managed

3.1 Passenger Vehicles (PV)

• Inventory across OEMs has been reduced to lean levels:

  • Maruti Suzuki: ~9 days of inventory, among the lowest in the industry.

  • Tata Motors: Less than 25 days of inventory — sharp reduction post-festive season.

• Companies are focused on retail-led sales, avoiding overstocking, and maintaining dealer health.

• Production aligned tightly with demand to avoid heavy discounting pressures.

3.2 Commercial Vehicles (CV)

• Selective inventory build in buses and passenger carriers to meet rising demand.

• SCV inventory being carefully managed, given weak demand.

3.3 Farm Equipment (Tractors)

• Inventory normalized and aligned to seasonal demand. No overhang expected going into Q4.

4. Pricing: Disciplined & Selective Increases

4.1 Recent Price Increases Implemented

• Most OEMs have taken price hikes of 0.8%–1% in Q4 FY25 to offset cost pressures:

  • Hyundai, Maruti, Tata, and Mahindra implemented small hikes.

• No aggressive pricing actions due to weak urban demand and price-sensitive segments.

4.2 Constraints on Future Price Hikes

• High discounting pressure in hatchbacks and sedans limits further hikes.

• Strong competitive intensity, especially in EVs, makes it challenging to raise prices aggressively.

4.3 Commodities Impact

• Commodity prices stable to softening, easing margin pressures and reducing the need for further hikes.

4.4 EV Pricing: Strategic Focus

• EV pricing is competitive but not excessively discounted.

• PLI benefits help cushion margins, but companies are focusing on cost reduction and localization to avoid passing all cost pressures to consumers.

5. Product Mix : Focus on Profitability & Growth

5.1 SUV and Premiumization Focus

• SUV contributions to sales are at historic highs:

  • Hyundai: 69%.

  • Tata Motors: 54%.

• OEMs are prioritizing high-margin, feature-rich SUVs over low-margin hatchbacks.

• High-end trims with sunroofs, ADAS, and automatics gaining traction, improving ASP and margins.

5.2 EV and CNG Expansion

• Aggressive focus on EVs and CNG:

  • Hyundai: Creta EV, dual-cylinder CNG.

  • Maruti: e-Vitara EV, CNG accounts for 1 in 3 cars sold.

  • Tata: Full EV range from Tiago to Harrier EV.

  • M&M: Born Electric platform, last-mile EV focus.

• Companies leveraging PLI benefits and localization to sustain competitiveness.

5.3 Alternative Fuels and Future Tech

• Exploring multi-fuel options — flex-fuel, hydrogen, biofuel.

• Hydrogen ICE and EVs presented at Bharat Mobility Expo by Tata and Hyundai.

• Preparing for regulatory shifts and long-term sustainability.

5.4 Export-Focused Product Strategy

• New models designed for domestic and global markets:

  • Maruti e-Vitara: "Made in India for the World".

  • M&M SUVs and pickups targeted for emerging markets (South Africa, Australia, Chile).

  • Tata and Hyundai expanding in LHD markets and Africa.

6. Conclusion: Emerging Themes for FY26

1. Moderation in growth, with SUV, EV, and rural as key drivers.

2. Margin protection through premiumization, tight inventory, and localization.

3. Strategic EV and alternative fuel push, backed by PLI.

4. Export diversification to hedge domestic demand risks.

5. Continued focus on multi-fuel readiness (ICE, EV, CNG, Hydrogen).

While demand growth is moderating, Indian auto OEMs are restructuring product mix, pricing, and inventories to adapt to a transforming landscape led by electrification and premiumization. SUVs, EVs, rural markets, and exports will be critical for sustaining growth and profitability in FY26.

Disclaimer

Content Accuracy and Reliability: This information is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities.

Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions.

No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary.

Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional.

Despite a traditionally softer third quarter, India’s leading IT services providers (including Infosys, TCS, Wipro, HCLTech, LTIMindtree, Tech Mahindra, and Persistent) collectively delivered stable-to-modest sequential revenue growth, strong bookings, and modest margin improvements in Q3 FY25. Management commentaries convey guarded optimism underpinned by the following trends:

1. BFSI Demand Gains Steam

• Return of Discretionary Spend: After a period of intense cost management, large banks in North America are gradually reviving budgets for discretionary projects. European financial institutions—previously more cautious—are also showing early signs of expanded activity.

• Cost Efficiency + Modernization: While cost-takeout pressures persist (leading to vendor consolidation and managed services deals), there is growing appetite for modernizing core banking, cloud infrastructure, and advanced analytics to drive future ROI.

• AI & Data-Driven Focus: BFSI stands out as a frontrunner in adopting Generative AI (GenAI) for real-time risk/fraud analytics and improved customer engagement. Many banks consider data modernization essential for scaling AI, spurring fresh investments in data platforms, governance, and cloud-based analytics.

2. Mixed Picture Across Other Verticals

• Retail & Consumer

  • US Retail Rebound: Retailers benefited from healthy holiday demand, and many have resumed selective discretionary spending. Focus areas include omnichannel modernization, AI-driven personalization, and dynamic pricing strategies.

  • Europe More Conservative: Retailers remain cautious but continue limited transformation efforts around supply chain and marketing analytics.

• Manufacturing

  • Muted in Auto/Aerospace: Persisting macro uncertainties and supply chain strains have led to delayed decision-making. Cost optimization remains a near-term priority.

  • Longer-Term Digital Factory Projects: Steady pipeline for Industry 4.0 (smart manufacturing, predictive maintenance) and ERP upgrades (e.g., S/4HANA). Large transformation deals are possible, albeit with extended cycles.

• Hi-Tech & Telecom

  • Efficiency-Led Engagements: With customers under margin pressure, deals emphasize cost reduction, vendor consolidation, and ROI-based modernization (cloud migration, DevOps).

  • AI Partnerships: Tech players lead in advanced AI solutions such as chip design for ML accelerators and agentic AI capabilities for contact centers or network management.

  • Telecom Focus: Telcos concentrate on cost-takeout, 5G expansions, and BSS/OSS modernization, often slicing large programs into smaller phases for faster returns.

• Healthcare & Life Sciences

  • Short-Term Hurdles, Medium-Term Optimism: Some client-specific slowdowns (especially smaller pharma/biotech), but top medtech and pharmaceutical majors continue to fund R&D transformation, AI-based drug discovery, digital manufacturing, and connected devices.

• Energy & Utilities

  • Modernization & Decarbonization: Oil/gas and utilities maintain IT spending around predictive maintenance, grid modernization, and renewables-driven projects.

  • Cloud & Data Analytics: Upstream operations increasingly adopt cloud-based platforms for geospatial analysis and remote asset management.

3. Large Deals & Cost Optimization

• High TCV & Modular Deals: Leading vendors announced robust total contract values (TCV), driven by multi-year cost-takeout plus transformation engagements. Many large programs are broken into smaller “compacts” for quicker ROI and risk mitigation.

• Shortened Deal Cycles: Several providers reported slightly faster conversion of mid-to-large deals, suggesting improved client confidence. BFSI and retail led in awarding bigger deals, reflecting an uptick in discretionary spend.

4. Generative AI as a Critical Growth Engine

• Moving Beyond PoCs: Clients are scaling AI from pilot chatbots toward advanced use cases—fraud detection, drug discovery, predictive maintenance, and “agentic AI” solutions that autonomously manage end-to-end business workflows.

• Data Modernization as a Prerequisite: Enterprises realize that building robust data lakes, governance structures, and cloud architectures is essential before deploying enterprise-grade AI. Many new deals bundle data modernization with GenAI implementations.

• Domain-Focused & Responsible AI: Providers increasingly offer vertical-specific or “small language models” (SLMs), ensuring specialized solutions for BFSI, retail, healthcare, and others. Governance and security measures remain top concerns, prompting emphasis on “responsible AI.”

5. Margins & Headcount: Stable to Improving

• Sequential Margin Gains: Despite Q3 headwinds (furloughs, fewer working days), most firms reported margin upticks. Wage and subcontracting costs have eased; enhanced productivity, utilization, and selective AI-based premium pricing also boosted profitability.

• Moderate Headcount Movement: Net additions were modest or slightly negative, reflecting both seasonal patterns and efficiency drives. Yet, companies underscored intact campus hiring plans and stable or declining attrition from earlier peaks.

6. Geographic & Outlook Highlights

• North America: BFSI and retail are the principal bright spots; new US government leadership and stable economic indicators could further reduce client hesitancy.

• Europe: Mixed macro but encouraging pipeline in BFSI, manufacturing, and the public sector. Discretionary spends remain cautious but show early signals of revival.

• Growth Markets (India, Middle East, Latin America): Double-digit growth continues, buoyed by government digitization projects, BFS expansions, and cloud/data transformations.

7. Future View (CY25/FY26)

• Macroeconomic Stabilization Boosts Spending Confidence

  • With inflation easing and interest rates stabilizing in key markets, most IT providers anticipate a more supportive business climate.

  • Clients appear incrementally more willing to undertake discretionary programs, especially in verticals like BFSI and Retail, though caution persists in Manufacturing and Hi-Tech.

• AI/GenAI Set to Remain a Growth Engine

  • Generative AI demand is poised to expand beyond proofs-of-concept, with enterprise-wide deployments for intelligent automation, data-driven insights, and predictive capabilities.

  • Providers expect increased deal sizes and faster decision cycles for AI-led transformation, underpinned by robust data modernization initiatives.

• Steady to Rising Large Deals and Pipeline

  • Momentum in large cost-takeout + transformation deals is expected to continue.

  • Many clients are also committing multi-year budgets for legacy modernization, cloud adoption, and advanced analytics, with a strategic goal of building “digital-ready” infrastructure.

• Consolidation and Efficiency Priorities

  • Enterprises will persist with vendor consolidation and “do more with less” themes, bundling run-cost optimization with big transformation mandates.

  • Outcome-based and risk–reward–linked engagements could see wider adoption as clients push for measurable returns and value metrics.

• Vertical-Specific Rebound Timelines

  • BFSI: Likely to remain among the fastest adopters of AI and a key source of large transformation wins.

  • Retail: US retailers’ improved holiday performance and e-commerce modernization bodes well for near-term growth.

  • Manufacturing: Outlook remains muted near term but broad-based digital factory initiatives suggest potential improvement in late 2025.

  • Hi-Tech & Telecom: More cautious spending on new projects, though efficiency and next-gen network modernization deals will persist.

  • Healthcare & Life Sciences: Should see a gradual pickup as pharma invests in AI-based R&D, though some near-term headwinds linger.

• Margin Tailwinds

  • Wage cost pressures are easing, subcontractor use is down, and attrition has normalized. Providers aim to leverage operational improvements (higher utilization, automation) plus selective price improvements (particularly for GenAI and specialized skill sets) to bolster margins.

  • Currency volatility remains a wild card, but overall, the margin environment is expected to remain supportive or improve slightly.

• Investments in Talent and Partnerships

  • Providers are scaling up AI, cloud, cybersecurity, and engineering talent pipelines, along with forging deeper alliances with hyperscalers and specialized AI solution partners.

  • Training, internal IP development, and selective tuck-in acquisitions (especially for domain-based AI) may continue to accelerate.

• Overall Conclusion

  • The IT services sector enters calendar 2025 with tempered optimism. While near-term budget scrutiny persists in some pockets, the overall direction is positive, bolstered by robust large deals, a resurgent BFSI segment, stable or improving pipeline conversion, and strong AI/GenAI adoption.

  • As global macro uncertainties recede, enterprises’ willingness to invest in digital modernization and data-driven transformation is expected to sustain IT services growth over the coming quarters.

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other profession

1. Executive Summary: Q3-25 Real Estate Market Insights

1.1 Financial Performance – Strong Growth & Liquidity

• Record-breaking sales: Macrotech (INR 4,507 Cr, +32% YoY), Godrej (INR 28,800 Cr, +69% YoY).

• Debt reduction & liquidity boost: Macrotech (-15% net debt), Godrej’s net debt-to-equity at 0.23 via INR 6,000 Cr QIP.

• Steady rental income: Brigade leasing revenue +13% YoY, Phoenix retail rentals +12% YoY.

1.2 Demand – Resilient Across Segments

• Residential demand strong: Brigade’s Hyderabad launch sold INR 1,000 Cr (200 units).

• Office leasing rebounds: Bangalore & Hyderabad lead, driven by IT & BFSI.

• Retail surges +21% YoY: Festive spending & luxury mall expansions fuel growth.

1.3 Inventory – Expanding to Meet Demand

• Large pipelines: Godrej (16 projects, 29.1 Mn sq. ft.), Brigade (15 Mn sq. ft.).

• Strategic expansions: Phoenix Mills enters Thane, Coimbatore, Chandigarh.

1.4 Pricing – Strong Upward Momentum

• Residential prices up 5-7% YoY, luxury at all-time highs.

• Premium housing leads: Brigade’s Bangalore at INR 30,000/sq. ft., Oberoi Realty hikes prices 20% in Thane, Borivali.

• Retail & office rentals rising: High-end malls, premium workspaces in demand.

1.5 Challenges – Regulatory Delays & Market Shifts

• Approval delays in Bangalore & Chennai slowing project launches.

• Affordable housing demand weak, shifting focus to mid-premium segments.

• High construction & land acquisition costs impacting margins.

• Retail rental growth slower in older malls, requiring upgrades & repositioning.

Sustained demand, strong pricing power, and robust financials position real estate for continued growth in FY26.

2. Financial Performance

2.1 Strong Revenue Growth and Profitability

• Residential Real Estate:

  • Macrotech Developers (Lodha) reported INR 4,507 crores in Q3 pre-sales, up 32% YoY, indicating strong demand in the mid-to-luxury segment.

  • Godrej Properties recorded its highest-ever annual sales at INR 28,800 crores, marking a 69% YoY increase, demonstrating robust consumer sentiment.

  • Brigade Enterprises achieved 37% sales growth in Q3 FY25, showing consistent demand across metro cities.

• Commercial and Retail Real Estate:

  • Phoenix Mills' retail business saw an increase in mall consumption, with retail rental income up 12% YoY.

  • Brigade Enterprises' office leasing business grew 13% YoY, with 99% rental collection efficiency, reflecting steady demand for Grade A office spaces.

2.2 Debt Reduction and Liquidity Improvement

• Developers have focused on reducing net debt and increasing liquidity to fund expansion:

  • Macrotech Developers reduced net debt by 15% to INR 4,300 crores, keeping its net debt-to-equity at 0.22x.

  • Godrej Properties raised INR 6,000 crores via QIP, bringing its net debt-to-equity ratio to 0.23 from 0.72, ensuring ample liquidity for future expansions.

2.3 Shift Towards High-Margin Segments

• Developers are prioritizing profitability by focusing on premium housing and mixed-use developments:

  • Brigade Enterprises saw an increase in its average price realization to INR 11,364 per sq. ft., up 5% QoQ, indicating a move towards premium housing.

  • Phoenix Mills expanded its luxury retail and hospitality portfolio, highlighting the profitability of high-end segments.

3. Demand Trends

3.1 Residential Market Remains Strong

• No visible slowdown in residential real estate demand, despite macroeconomic uncertainties.

• Key demand drivers:

  • Urbanization and rising income levels

  • Preference for larger homes post-pandemic

  • Demand for premium and luxury homes

  • Rise in NRI investments in Indian real estate

• Strong performance in major metro cities:

  • Mumbai: Macrotech Developers' Western Suburbs sales doubled YoY, demonstrating Mumbai’s sustained high-end demand.

  • Hyderabad: Brigade Enterprises’ Brigade Gateway (Kokapet) project saw 200 units sold at INR 1,000 crores, making it Hyderabad’s most successful launch of the year.

  • Bangalore: Godrej Properties doubled its Bangalore sales, reflecting sustained IT-sector-driven housing demand.

3.2 Commercial and Retail Demand Rebounding

• Office leasing is witnessing strong recovery:

  • Bangalore and Hyderabad led the leasing activity, driven by global capability centers, IT, and BFSI companies.

  • Retail consumption surged 21% YoY, fueled by discretionary spending and strong mall footfalls.

• Luxury and premium retail outperforming:

  • Phoenix Mills' Palladium Mall expansion and Brigade's Orion Mall pipeline indicate rising luxury retail demand.

4. Inventory Levels

4.1 New Supply Pipeline Remains Strong

• Developers are aggressively replenishing their inventory:

  • Godrej Properties added 16 projects, with a total saleable area of 29.1 million sq. ft..

  • Brigade Enterprises has a pipeline of 15 million sq. ft. in Bangalore, Hyderabad, Chennai, and Mysore.

4.2 Geographic Diversification of Inventory

• Expansion into Tier 2 markets and new geographies:

  • Phoenix Mills expanded into Thane, Coimbatore, and Chandigarh, ensuring future pipeline visibility.

  • Brigade Enterprises increased focus on Hyderabad, with plans for new projects beyond Kokapet.

5. Pricing Trends

5.1 Residential Pricing on the Rise

• Average annual price growth: 5-7% expected across segments.

• Macrotech Developers reported 4% YTD price growth, in line with its annual 5-7% target.

• Brigade Enterprises achieved 30% per sq. ft. rates in select premium projects.

5.2 Luxury Housing Seeing Strongest Growth

• Brigade Enterprises’ luxury homes in Bangalore and Hyderabad saw pricing approach INR 30,000 per sq. ft..

• Oberoi Realty hiked prices by 20% in Thane, Borivali, and Goregaon, citing high secondary market appreciation.

5.3 Office and Retail Rentals Strengthening

• Office lease rates improved due to increased corporate demand.

• Retail rental growth reached 12% YoY, with luxury retail spaces seeing the highest gains.

6. Challenges Across Segments

6.1 Residential

• Approval Delays:

  • Bangalore and Chennai have seen slower regulatory approvals, affecting project timelines.

• Affordable Housing Demand Weakening:

  • Developers are focusing on mid-to-premium segments, as demand for affordable housing remains weak.

6.2 Commercial

• Work-from-home impact on Grade B office demand

  • While Grade A spaces continue to perform well, smaller office spaces are seeing slower leasing.

• Strata Sale vs. Leasing Dilemma:

  • Brigade Enterprises is selling strata office units, while leasing Grade A spaces, leading to a strategic balancing act.

6.3 Retail

• Retail Rental Growth Slower in Older Malls:

  • Older malls require category upgrades and premiumization to maintain footfalls and consumption levels.

6.4 Liquidity and Costs

• Rising Construction Costs:

  • Developers have had to increase pricing to maintain margins, as input costs (cement, steel) remain high.

• High Land Acquisition Costs:

  • Mumbai and Bangalore developers noted that landowners are demanding premium pricing, making it harder to acquire cost-effective parcels.

7. Conclusion: Positive Outlook with Strategic Adjustments

• The real estate sector remains strong across residential, commercial, and retail segments.

• Developers are optimizing their product mix by focusing on high-margin luxury and premium housing.

• Inventory pipelines remain healthy, ensuring long-term sustainability of growth.

• Pricing power is strong, especially in luxury and commercial segments.

• Challenges exist, but leading players are mitigating risks via strategic expansions, debt reduction, and price recalibration.

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities. Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions. No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary. Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

Contents

1. Overall Trends: Q3-25 Indian Pharma Companies

2. Financial Performance Trends

3. Trends in India Business

4. Trends in the US Market

5. Product Pipeline Trends

6. Regulatory Compliance Trends

1. Overall Trends: Q3-25 Indian Pharma Companies

1.1 Revenue & Profitability Growth

• Most companies reported revenue growth in the range of 8% to 17% YoY.

• Sun Pharma, Zydus Lifesciences, and Cipla recorded strong double-digit growth, while Aurobindo Pharma and Mankind Pharma also reported solid revenue increases.

• EBITDA margins improved, mainly due to better product mix, cost efficiencies, and strong specialty and chronic segment performance.

1.2 Domestic Market Performance

• Strong growth in the chronic segment (cardiology, anti-diabetes, respiratory, oncology).

• Cipla & Zydus Lifesciences outperformed the Indian Pharmaceutical Market (IPM), with Cipla’s One India Business growing at 10% YoY and Zydus reporting an 8% growth in its domestic formulations.

• Mankind Pharma continued its expansion in high-margin chronic therapy areas, with chronic share increasing to 37.6%.

1.3 US Market & Specialty Business

• The US market remains mixed, with price erosion in generics still a challenge (5-10% erosion across portfolios).

• Companies with strong specialty and complex generics portfolios performed better.

  • Sun Pharma: Specialty business grew 24.8% YoY, led by ILUMYA, CEQUA, ODOMZO, and WINLEVI.

  • Cipla: North America revenue at $226M, but some impact from Lanreotide supply disruptions.

  • Dr. Reddy’s: US business impacted by lower Revlimid sales but offset by new launches.

1.4 Trade Generics & OTC Growth

• Trade generics business in India showed mixed results:

  • Alkem Labs: Trade generics remained flat, while branded generics grew 7.5%.

  • Cipla: Trade generics are back to growth mode after model transition.

  • Zydus & Mankind: OTC business grew over 15% YoY, supported by volume growth.

1.5 Investments in R&D & Specialty Expansion

• Biosimilars & Specialty Portfolio Expansion:

  • Dr. Reddy’s & Aurobindo are investing heavily in biosimilars like Rituximab, Denosumab, and Abatacept.

  • Zydus & Cipla are focused on 505(b)(2) products in the US.

  • Sun Pharma has acquired Antibe Therapeutics, focusing on pain management without opioids.

• R&D spending stabilized at 5-7% of revenue, with most companies focusing on complex generics, biosimilars, and innovation-driven products.

1.6 International Markets & Emerging Markets Performance

• Aurobindo & Sun Pharma posted strong growth in emerging markets.

• China & Europe expansion gaining momentum for Aurobindo.

• Zydus & Cipla reported high double-digit growth in South Africa & Europe.

1.7 Key Challenges & Risks

• USFDA inspections & regulatory issues: Cipla’s Goa plant clearance was a relief, but other companies (Aurobindo & Dr. Reddy’s) faced Form 483 observations.

• Raw material cost volatility: Some companies benefitted from lower input costs, but uncertainty remains.

• Price erosion in US generics continues to impact profitability, forcing companies to shift focus to specialty & complex generics.

1.8 The Big Picture

• India’s pharmaceutical industry is shifting towards high-margin businesses (chronic therapies, biosimilars, and specialty drugs).

• Trade generics are stabilizing, but competitive pressures are high.

• US generics remain challenging, but new product launches and specialty focus are driving growth.

• R&D investments in biosimilars and novel therapies are key growth drivers for the future.

2. Financial Performance Trends

Indian pharmaceutical companies reported mixed financial performance in Q3 FY25, with strong growth in specialty & chronic segments, price erosion challenges in US generics, and regulatory headwinds affecting product launches.

2.1 Revenue Growth: Strong Domestic, Mixed US Performance

• Domestic revenue growth outpaced the market, driven by chronic therapies & branded generics.

• US revenue performance was mixed, with some companies facing price erosion & regulatory delays.

• Pharma companies posted double-digit growth in India & emerging markets, while the US market remained volatile due to pricing pressure.

2.2 Profitability: Specialty & Cost Control Driving Margins

• Companies with strong specialty portfolios (Sun, Dr. Reddy’s, Cipla) expanded margins, while those relying on generics (Aurobindo, Alkem) faced pricing pressure.

• Raw material cost stabilization supported gross margins.

  

2.3 Net Profit Performance: Driven by Operational Efficiency

• Net profits grew for most companies, supported by cost efficiency & domestic business strength.

• Sun Pharma, Cipla, & Zydus Lifesciences posted strong net profit growth, while Dr. Reddy’s saw lower gains due to one-time integration costs.

  

2.4 Regional Growth: India & Emerging Markets Leading

• India outperformed the US for most companies, driven by chronic therapies & branded generics.

• Emerging markets (Europe, LATAM, Asia) grew in double digits.

2.5 R&D Investments: Focus on Specialty, Biosimilars & Injectables

• R&D focus is shifting toward biosimilars, injectables, and specialty drugs to drive high-margin future growth.

• Companies are spending 5-7% of revenue on R&D, with a focus on biosimilars, complex generics & injectables.

• Sun Pharma & Dr. Reddy’s are leading investments in specialty drugs.

3. Trends in India Business

3.1 Strong Growth in Chronic Therapies

• Chronic therapy segments (cardiology, anti-diabetes, respiratory, oncology, neurology) continued to outperform the market.

• Cipla: Chronic mix improved to 61.5% of revenues.

• Zydus Lifesciences: Cardiology, respiratory, and oncology outperformed.

• Mankind Pharma: Chronic business grew 1.3x the market, with CVM (cardio-metabolic-vascular) segment improving from 4th to 3rd rank.

3.2 Volume & New Launches Driving Growth

• Unlike previous quarters where price increases drove growth, Q3 FY25 growth was led by volume expansion and new product launches.

• Sun Pharma: Gained market share with volume-led growth and new launches.

• Zydus Lifesciences: Reported 8% secondary sales growth, led by chronic expansion.

• Alkem Labs: Flagship brands saw 8% value growth, with 32 brands increasing market share YoY.

3.3 Acute Therapy Growth Remains Weak

• The acute segment saw lower growth across most companies.

• Mankind Pharma: Acute segment growth was soft due to market-wide slowdown and internal restructuring.

• Cipla: Acute portfolio performance was weak, impacting overall branded business growth.

• Alkem Labs: Outperformed the acute market, growing 5.9% vs. market growth of 5.7%, but still slower than the chronic segment.

3.4 Trade Generics & OTC Business: Mixed Performance

• The trade generics segment had mixed results due to pricing pressure and higher competition.

  • Alkem Labs: Trade generics business was flat, while branded generics grew 7.5%.

  • Cipla: Trade generics returned to growth post-restructuring.

  • Mankind Pharma: OTC business grew 30% YoY in Q3 FY25.

  • Zydus Lifesciences: OTC business up 13% YoY, led by personal care & nutrition products.

3.5 Expansion into High-Margin Specialty & Super-Specialty

• Companies are shifting toward high-margin specialty segments in India.

• Mankind Pharma: Acquisition of BSV (Bharat Serums & Vaccines) strengthens high-entry barrier portfolios in oncology, nephrology, and fertility.

• Cipla: Foracort remains India’s #1 respiratory brand, and expansion into biologics and inhalation therapies continues.

3.6 Field Force Expansion & Digital Initiatives

• Companies are increasing medical representative (MR) strength to expand doctor coverage.

  • Sun Pharma: Field force at 14,000+ MRs.

  • Cipla: Added 1,800 field reps in chronic therapies.

  • Mankind Pharma: Restructuring its field force for greater efficiency in high-growth areas.

• Digital transformation continues:

  • Cipla launched CipAir, an AI-powered asthma screening tool.

  • Zydus & Sun Pharma investing in doctor engagement platforms.

3.7 Price Growth in NLEM (National List of Essential Medicines) Affected Profitability

• Companies with a high NLEM exposure faced challenges in price hikes, as NLEM pricing remains controlled by the government.

• Alkem Labs: Large NLEM portfolio impacted pricing, but volume growth helped offset losses.

• Mankind Pharma: Focus on volume expansion to counter lower price hikes.

4. Trends in the US Market

The US market remains a mixed bag for Indian pharma companies in Q3 FY25. While specialty businesses and complex generics showed strong growth, price erosion in the generics segment continues to be a major challenge.

4.1 Price Erosion in US Generics Continues

• Price erosion remains in the range of 5-10% YoY, affecting most companies.

• Dr. Reddy’s: Reported a flat YoY performance in the US, with continued price erosion offsetting volume growth.

• Cipla: Price erosion in some segments was higher than expected, but it remains within a high single-digit range.

• Aurobindo Pharma: The company reported mid-single-digit price erosion, but managed to offset it with new launches.

4.2 Specialty Business Driving Growth

• Indian pharma companies are shifting focus to specialty products in the US, which have higher margins and lower competition.

• Sun Pharma: Specialty business grew 24.8% YoY, driven by:

  • ILUMYA (Psoriasis)

  • CEQUA (Ophthalmology)

  • ODOMZO (Oncology)

  • WINLEVI (Dermatology)

• Cipla: Respiratory franchise performing well, with Albuterol market share reaching 21%.

• Dr. Reddy’s: Biosimilars & complex generics in focus, with Denosumab and Rituximab filed for approval.

4.3 New Product Launches Supporting Growth

• Cipla: New approvals for Esomeprazole Granules, Potassium Phosphates Injection, and Phytonadione Injectable.

• Aurobindo Pharma: Launched 7 new products in Q3 and received 8 ANDA approvals.

• Dr. Reddy’s: Filed 15-20 ANDAs for the full year and continues to launch complex injectables.

• Zydus Lifesciences: Launched 5 products, including Sitagliptin 505(b)(2) franchise with CVS Caremark.

4.4 Growth in Injectables & Biosimilars

• The injectables market is seeing high growth, with companies investing in expanding their US injectable portfolio.

• Aurobindo Pharma: Focus on injectables & complex generics, with 60-70% capacity utilization at Eugia-3.

• Zydus Lifesciences: Entered 505(b)(2) segment with Sitagliptin, a specialty diabetes treatment.

• Dr. Reddy’s: Expanding biosimilars pipeline, with Denosumab filed in both US & EU.

4.5 Regulatory Challenges & FDA Inspections

• FDA inspections remain a key risk, with multiple plants receiving Form 483 observations.

• Dr. Reddy’s CTO-2 plant (Bollaram, Hyderabad): Received 7 observations from USFDA.

• Aurobindo Pharma: Expecting inspections at its China & US plants before full commercialization.

• Cipla’s Goa Plant: Received VAI (Voluntary Action Indicated) classification, clearing regulatory hurdles.

• Sun Pharma: Facing US opioid litigation settlement.

4.6 Revlimid & GLP-1 Opportunities

• Revlimid (Lenalidomide) impact:

  • Dr. Reddy’s & Cipla reported flat Revlimid sales QoQ, as market penetration reached saturation.

  • Sun Pharma reported lower Revlimid sales in Q3, impacting overall US revenue.

• GLP-1 (Weight Loss & Diabetes) Focus:

  • Dr. Reddy’s & Aurobindo: Developing Semaglutide generics for US/Canada markets.

  • Alkem Labs: Filed for GLP-1 approval in India, aiming for first wave entry.

4.7 Expansion of US Manufacturing & Capacity

• To counter tariff concerns, companies are investing in US-based manufacturing.

• Cipla: Investing $100M in its US facilities for DPI/MDI (inhalation) and injectable production.

• Aurobindo Pharma: Expanding Dayton & Raleigh plants to manufacture OSD & transdermal products.

• Dr. Reddy’s: Ramping up biologics & transdermal manufacturing for US/EU markets.

5. Product Pipeline Trends

✅ Specialty drugs (dermatology, ophthalmology, oncology) & complex generics are driving future growth.
✅ Biosimilars (Denosumab, Rituximab, Omalizumab) are gaining traction in US & EU.
✅ GLP-1 therapies (Semaglutide, Tirzepatide) are a big focus for diabetes & weight-loss markets.
✅ Injectables (oncology, depot injections, respiratory) are seeing high growth potential.
✅ Regulatory approvals & ANDA filings are shifting towards high-margin, low-competition products.

Overall, Indian pharma companies are transitioning from traditional generics to high-margin specialty drugs, injectables, and biologics to counter price erosion and drive profitability.

Would you like company-specific insights on pipeline products? Let me know! 🚀

5.1 Specialty & Complex Generics: Driving Future Growth

• Sun Pharma: Specialty business led by ILUMYA (psoriasis), CEQUA (ophthalmology), ODOMZO (oncology), and WINLEVI (dermatology).

• Dr. Reddy’s: Expanding transdermal & respiratory portfolios. Filed Denosumab (osteoporosis) in US & Europe.

• Zydus Lifesciences: Entered the 505(b)(2) market with Sitagliptin, targeting diabetes treatment.

• Cipla: Respiratory expansion continues, with Albuterol and potential Advair & Symbicort generics.

5.2. Biosimilars & Biologics Pipeline Gaining Momentum

Biosimilars are a long-term focus, with companies preparing for high-margin, low-competition opportunities.

• Dr. Reddy’s:

  • Filed Rituximab (oncology) in UK.

  • Denosumab (osteoporosis) submitted in the US & Europe.

  • Omalizumab (Xolair biosimilar) in Phase III clinical trials.

• Aurobindo Pharma:

  • Focusing on biosimilar production at its US & China plants.

  • Scaling up Pen-G API for antibiotic biosimilars.

• Zydus Lifesciences:

  • Completed Phase III trials for a biosimilar antibody-drug conjugate (ADC).

  • Awaiting DCGI approval for new biosimilars.

• Sun Pharma: Exploring biosimilar development but has not committed fully.

5.3 GLP-1 & Diabetes Pipeline Expansion (Semaglutide, Tirzepatide, etc.)

GLP-1s are expected to be a multi-billion-dollar opportunity, with Indian pharma looking to capture the generic wave. GLP-1 receptor agonists (used for weight loss & diabetes) are a major focus area for Indian pharma.

• Dr. Reddy’s & Aurobindo Pharma: Developing Semaglutide (Ozempic/Wegovy biosimilar) for the US & Canada.

• Alkem Labs: Filed for GLP-1 approval in India; aims to be among the first entrants in the domestic market.

• Zydus Lifesciences:

  • Signed a deal with CVS Caremark for Sitagliptin (diabetes).

  • Developing novel diabetes biologics.

5.4 Respiratory & Inhalation Therapies

Inhalation therapies & respiratory biologics remain a focus, especially in the US & India.

• Cipla:

  • Advair (fluticasone/salmeterol) launch expected in FY26.

  • Symbicort (budesonide/formoterol) filing completed.

  • Partnered inhalation drug launch in FY26.

• Dr. Reddy’s:

  • Expanding respiratory biologics portfolio.

  • Toripalimab (immuno-oncology drug) launched in India.

5.5 Injectable & Complex Generic Expansion

Injectables remain a major high-growth segment, with companies building strong US portfolios.

• Aurobindo Pharma:

  • Filed 4 new ANDAs in Q3 and received 8 approvals.

  • Expanding injectables & depot injections portfolio.

• Dr. Reddy’s:: Investing in complex injectables & high-barrier formulations.

• Cipla:

  • Lanreotide (Somatuline Depot generic) supply to normalize by Q4 FY25.

  • Launched Phytonadione Injection, Esomeprazole Granules, Potassium Phosphates Injection.

• Zydus Lifesciences: Entered the US oncology injectables space with new filings.

5.6 Oncology & Immunotherapy Pipeline

Oncology continues to be a high-value segment, with a shift toward biologics & targeted therapies.

• Sun Pharma:

  • Expanding dermatology-oncology portfolio, with global ILUMYA expansion.

  • Acquired Antibe Therapeutics (pain management without opioids).

• Zydus Lifesciences:

  • Developing ADC biosimilars for targeted cancer treatment.

  • Ongoing Phase II trials for novel oncology treatments.

• Dr. Reddy’s:

  • Launched Toripalimab (immuno-oncology drug) in India.

5.7 ANDA Filings & USFDA Approvals

Companies are increasing filings in specialty areas, including injectables, biosimilars & respiratory drugs.

• Dr. Reddy’s: Filed 23 ANDAs in Q3, focusing on complex generics & biosimilars.

• Aurobindo Pharma: 60+ ANDAs pending approval, focusing on injectables & oral solids.

• Cipla: Filed multiple 505(b)(2) applications, focusing on respiratory & peptides.

• Zydus Lifesciences:

  • 10 ANDA filings & 3 approvals in Q3.

  • Strengthening neurology, oncology & dermatology pipeline.

6. Regulatory Compliance Trends

Regulatory compliance remains a major focus area for Indian pharmaceutical companies, particularly for USFDA inspections, Form 483 observations, and site clearances. The overall trend suggests increased regulatory scrutiny, especially for injectables, biosimilars, and high-risk manufacturing sites.

6.1 Increased USFDA Inspections & Form 483 Observations

• Several Indian pharma companies faced USFDA inspections, with some receiving Form 483 observations.

• Stricter compliance measures are being implemented to prevent import alerts and maintain supply chain integrity.

• USFDA inspections are becoming more frequent, especially for API plants, sterile injectables, and biosimilar facilities.

Companies Facing USFDA Observations in Q3 FY25:

• Dr. Reddy’s

  • Bollaram (CTO-2) plant received 7 observations after an inspection in November 2024.

  • Responded within the stipulated timeline; awaiting further action from USFDA.

• Aurobindo Pharma

  • Ramping up regulatory compliance at US & China facilities before commercialization.

  • Some pending approvals delayed due to additional FDA queries.

• Cipla

  • Goa plant received a VAI (Voluntary Action Indicated) status, indicating minor compliance issues but no major concerns.

  • Bengaluru Virgonagar plant received 8 Form 483 observations; awaiting USFDA classification.

• Sun Pharma

  • Ongoing regulatory scrutiny due to the US opioid litigation; company agreed to a $38M settlement for certain plaintiffs.

• Zydus Lifesciences

  • No major regulatory concerns reported in Q3 FY25, but closely monitoring compliance at US & India sites.

6.2 Manufacturing Site Remediation & Compliance Upgrades

• Companies are proactively addressing compliance gaps to avoid costly regulatory actions.

• Companies are investing in compliance improvements to meet stringent USFDA & EMA (European Medicines Agency) requirements.

• Many companies are remediating their plants to prevent potential warning letters & import bans.

Key Actions Taken:

• Cipla

  • Completed remediation of its Goa facility (which had earlier faced FDA scrutiny).

  • Strengthening quality & compliance at Bengaluru & Indore sites.

• Dr. Reddy’s

  • Strengthening data integrity systems across manufacturing sites.

  • Implementing AI-based compliance monitoring for batch production records.

• Aurobindo Pharma

  • Enhancing quality control measures at its China API plant before commercialization.

  • Dayton (US) & Raleigh (US) injectable plants undergoing pre-approval compliance checks.

• Sun Pharma

  • Investing in IT-based quality control systems to minimize human errors & automate batch reporting.

6.3 Biosimilars & Injectables Facing Stricter Oversight

• Biosimilar approvals are becoming more complex, with regulators demanding extensive clinical & quality data before approvals.

• Biosimilars & injectables require higher regulatory scrutiny due to their complex manufacturing & sterility requirements.

Companies Focusing on Biosimilar & Injectable Compliance:

• Dr. Reddy’s

  • Filed Denosumab & Rituximab in the US & EU, requiring GMP certifications from FDA & EMA.

  • Expanding injectable capacity while ensuring compliance with sterility norms.

• Aurobindo Pharma

  • Eugia-3 (injectables) ramping up production with 60-70% capacity utilization.

  • Undergoing pre-approval inspections for key filings.

• Sun Pharma

  • Focusing on dermatology & ophthalmology biosimilars to avoid complex regulatory delays.

6.4 Global Compliance Trends: EMA, TGA, and WHO Inspections

• Europe & other global markets are tightening their compliance requirements, forcing companies to maintain high-quality standards globally.

• Besides USFDA, companies are also undergoing EMA (Europe), TGA (Australia), and WHO (World Health Organization) inspections.

Recent Global Regulatory Inspections:

• Aurobindo Pharma

  • China plant received EMA clearance for solid oral dosages; awaiting USFDA inspection.

• Zydus Lifesciences

  • EU-GMP compliance obtained for biosimilars; expanding European footprint.

• Sun Pharma

  • EMA inspection completed at a key oncology formulation site.

6.5 Regulatory Delays & Impact on Product Approvals

• Regulatory delays are impacting product launches, especially for biosimilars & complex injectables.

• USFDA’s additional scrutiny is leading to slower ANDA approvals.

• Regulatory timelines for approvals are increasing, forcing companies to plan launches well in advance

Companies Facing Regulatory Delays:

• Cipla

  • Advair generic delayed to H2 FY26 due to additional regulatory review.

  • Abraxane launch postponed to late FY26, awaiting final approval.

• Dr. Reddy’s

  • US FDA delays impacting niche product approvals in oncology & respiratory segments.

• Aurobindo Pharma

  • Waiting for inspection clearance before full-scale biosimilar commercialization.

Disclaimer

Content Accuracy and Reliability: This summary of the earnings call is generated using an artificial intelligence large language model (LLM). While every effort has been made to ensure the accuracy and completeness of the information, the summary may not fully capture all nuances or details of the original earnings call. The content provided is for informational purposes only and should not be construed as financial advice or a recommendation to buy or sell any securities.

Verification: Readers are encouraged to refer to the official earnings call transcript, company filings, and other authoritative sources for comprehensive and accurate information. The creators of this summary do not guarantee the accuracy, completeness, or timeliness of the information and accept no responsibility for any errors or omissions.

No Liability: The use of this summary is at your own risk. The creators and distributors of this content disclaim any liability for any loss or damage arising from the use of or reliance on this summary.

Consult Professional Advice: For investment decisions or financial advice, please consult a qualified financial advisor or other professional

Table of Contents

1. Overall Performance in Q3 FY25: Macroeconomic Uncertainty

2. Analysis of Q3 FY25 Earnings

3. Loan Growth: Overall Cautious Growth

4. Deposit Growth Strategies: Balancing growth & quality

5. Asset Quality: Overall Stability with Emerging Concerns

6. Credit Quality: Rising stress

7. Credit Costs Rising and Normalisation of Credit Cycle

8. Sources

1. Overall Performance in Q3 FY25: Macroeconomic Uncertainty

• Insights from Q3-25 performance of top 5 private sector banks by market cap i.e. HDFC, ICICI, Axis, Kotak Mahindra & IndusInd Bank

• Macroeconomic Uncertainty: All banks acknowledge a challenging and volatile macroeconomic environment including tight liquidity, geopolitical uncertainty and inflationary pressures. This leads to a cautious approach to growth and increased focus on asset quality and risk management.

• Deposit Growth and CASA Ratio: Deposit growth and maintaining a healthy CASA (Current Account Savings Account) ratio are major concerns. Banks are focused on granularising their deposit base and improving the quality of their LCR (Liquidity Coverage Ratio) deposits, although some are struggling with deposit growth in the current environment.

• Asset Quality Monitoring: Banks are closely monitoring asset quality, particularly in unsecured lending (personal loans, credit cards), microfinance, and the agricultural sector. They are employing tighter underwriting standards and strengthened collection efforts.

• Strategic Focus: Banks are emphasising customer centricity, digital transformation, and building a resilient, "all-weather" franchise. They are also focused on optimising cost structures and improving efficiency.

• Profitability: While most banks demonstrated healthy profit growth, some faced NIM pressures due to rising costs and portfolio mix.

• Future Outlook: The outlook is cautiously optimistic, with banks focusing on sustainable growth, balance sheet strength, and customer-centric approaches to navigate the evolving economic landscape.

2. Analysis of Q3 FY25 Earnings

Profitability Trends

• ICICI Bank's Q3 FY2025 earnings call highlights a strong financial performance with profit after tax growing by 14.8% year-on-year to 117.92 billion Rupees. The profit before tax excluding treasury grew by 12.8% year-on-year to 152.89 billion Rupees. Core operating profit also saw an increase, growing 13.1% year-on-year.

• Kotak Mahindra Bank's consolidated profit reached Rs 4,700 crore, a 10% year-on-year increase. The bank's customer assets grew by 15% year-on-year, and deposits increased by 16%. Net Interest Margin (NIM) remained stable at 4.93%.

• Axis Bank reported a 14% year-on-year increase in core operating profit, driven by income growth and moderated expense growth. Consolidated Return on Assets (ROA) was 1.71% and Return on Equity (ROE) was 15.8%.

• HDFC Bank reported that Net Interest Margins (NIMs) have remained reasonably range-bound and stable despite the headwinds from tight liquidity, leading to a tight pricing environment.

• IndusInd Bank, however, saw Net Interest Margin (NIM) impacted, registering 3.93% versus 4.08% QoQ. This was attributed to lower QoQ average balances for microfinance and EBLR repricing, while the cost of funds was sequentially higher due to increased deposit costs and higher borrowings QoQ. The operating profit for the quarter was stable QoQ at Rs 3,601 crores.

Asset Quality and Credit Costs

• Asset quality is a focal point across the earnings calls, particularly concerning non-performing assets (NPAs) and provisioning.

• ICICI Bank reported gross NPA additions of 60.85 billion Rupees in the current quarter, compared to 50.73 billion Rupees in the previous quarter. Recoveries and upgrades from gross NPAs were 33.92 billion Rupees. The provisioning coverage ratio on non-performing loans was 78.2% at December 31, 2024.

• Axis Bank's gross NPA (GNPA) stood at 1.46%, declining 12 bps year-on-year. Net NPA (NNPA) was 0.35%, largely flat year-on-year and QOQ, with a Provision Coverage Ratio (PCR) of 76%. Net slippages in the quarter were Rs. 3,517 crores, increasing 48% QOQ.

• HDFC Bank's earnings call highlighted that, excluding seasonal agri loans, slippages were flat period-to-period. The overall PCR was about 68%, but excluding seasonal agri loans, PCR was 71%, consistent with the prior quarter.

• IndusInd Bank saw gross slippage ratio at 0.62% versus 0.56% YoY. The earnings call transcript noted that while slippages may get elevated for another quarter, their customer base is showing early signs of stability which should start reflecting from Q1 onwards.

• Kotak Mahindra Bank's gross NPA was at 1.5%, with net NPA at 0.41%, and the provision coverage ratio improved to 73%. Slippages during Q3 were lower compared to Q2.

Strategic Outlook and Future Initiatives

• ICICI Bank aims to drive risk-calibrated profitable growth by focusing on customer relationships, an extensive franchise, and collaboration within the organization, supported by investments in technology and distribution.

• Kotak Mahindra Bank is focused on customer centricity and transforming for scale, expecting these efforts to reflect in future results. The bank is also working through a strategy accepted by RBI, and is operating within a LDR range that has been consistent for five quarters.

• Axis Bank is focused on becoming a resilient, all-weather franchise by improving deposit quality and retail asset quality, and managing costs. The bank emphasized a focus on building a granular deposit book and is not necessarily running after lumpy deposits.

• HDFC Bank aims to grow and bring down the credit deposit ratio as quickly as possible over a 2- to 3-year timeframe.

• IndusInd Bank is cautious on the microfinance segment and expects retail loan share to start inching up again. The bank aims to granularize its liability by reducing bulk deposits and expects to have 48% to 50% share of retail LCR deposits with a Loan Deposit Ratio of around 88% to 90%.

3. Loan Growth: Overall Cautious Growth

• Overall Cautious Growth: Banks appear to be prioritizing prudent and sustainable growth over aggressive expansion. This suggests a broader industry trend towards measured lending strategies, taking into account asset quality, economic conditions and regulatory guidance.

• Deposit Growth as a Constraint: Deposit growth is seen as a key constraint for the growth in advances. Banks recognize that the ability to expand their loan portfolios is directly linked to their capacity to gather deposits. Banks are implementing strategies to enhance deposit quality and granularization, which will be key for sustainable growth.

• Focus on Asset Quality: Asset quality is a significant concern, particularly in unsecured loan segments. Banks are closely monitoring delinquencies and implementing stricter underwriting standards. This suggests that banks will likely remain cautious about unsecured lending and focus on secured assets to maintain a healthy portfolio.

• Strategic Calibration: Banks are actively calibrating their loan growth through credit and pricing models. This involves adjusting lending rates and tightening credit standards based on risk assessments and market conditions. Such calibration is a way to manage risk while optimizing profitability.

• Cyclical and External Factors: Banks acknowledge that their performance is subject to cyclical economic factors and external events. This includes being prepared for potential economic slowdowns, changes in interest rates, and the impacts of geopolitical events.

• Nuances in Retail Lending: The trends in retail lending demonstrate a nuanced approach, with variations across different product types. For example, while some segments like mortgages and auto loans are growing steadily, others like personal loans may experience deceleration. Banks are adapting to these variations by focusing on specific customer segments and tailoring their offerings accordingly.

• Corporate Sector Engagement: In the corporate sector, banks are moving away from simply chasing loan growth and are instead focusing on building long-term relationships with corporate clients. This involves understanding their clients' needs and providing tailored financial solutions that align with their strategic goals.

• Technology and Collection: Banks are leveraging technology to improve their collection capabilities and monitor their portfolios effectively. Investment in technology and analytics allows banks to identify early warning signs and take proactive measures to mitigate risks.

• Regional Factors: Banks need to be aware of regional factors that may affect loan growth. For example, one bank noted that it is closely watching how new microfinance regulations in Karnataka develop and whether they spread to other states.

4. Deposit Growth Strategies: Balancing growth & quality

Deposit growth strategies strategies emphasize balancing growth with quality, managing costs, and leveraging technology to enhance customer engagement and expand market reach.

Balancing Deposit Growth with Quality:

• Focus on Granular Deposits: A key strategy is to prioritize the acquisition of granular deposits over lumpy, high-value deposits that may be sensitive to pricing. Granular deposits, which consist of a large number of smaller accounts, provide a more stable funding base and reduce the risk of sudden outflows. One bank is focused on building a granular deposit book, and is not running after lumpy deposits, which are one on the back of pricing, which can lead to volatility in books.

• Improve Deposit Quality: Banks aim to improve the quality of their LCR (Liquidity Coverage Ratio) deposits to improve outflow ratios. Project Triumph, a bank-wide deposit transformation program, aims to improve the granularization of deposits and improve the operating rhythm of the franchise. Another bank improved the granularization in their deposit book, which positively impacts the quality of LCR deposits, improving the outflow ratio by 320 bps over the last 2 to 3 years.

Managing the Cost of Deposits:

• Control cost of funds: Banks aim to demonstrate a controlled increase in the cost of funds. The increase in cost of deposit remains contained at 3bps increase QoQ, mainly driven by change in mix.

• Offer competitive rates: Banks intend to reduce the differential between their rates and those of their competitors. Banks also intend to ensure that they generate deposits of the right kind at the right price, and all these factors are feeding into each other.

• Balance CASA, ActivMoney and TD: Banks seek to strike a balance between savings, ActivMoney and term deposits in a granular manner to achieve growth targets.

Leveraging Digital Channels and Technology:

• Enhance digital capabilities: Banks are improving digital capabilities to mobilise deposits and to encourage customers to use digital platforms. A direct digital model is scaling.

• Expand digital offerings: Banks are launching new products including a personal finance management tool and making enhancements to their products including redesign of several journeys. A bank has also launched INDIE for Business – a one of its kind industry first solution to bring “better business banking” to all MSME clients in the country.

• Focus on Transacting Platforms: Banks believe that their transacting platforms are pretty strong and their whole objective is to get more and more adoption of those by their existing customers and acquire more and more new customers on the strength of those platforms across the entire spectrum from large corporates to small businesses.

Expanding Market Reach and Customer Engagement:

• Branch Expansion: Despite the growing emphasis on digital channels, some banks continue to expand their branch networks, particularly in rural areas. A bank opened 130 new branches in the last three months, and 330 in the first nine months of this fiscal.

• Targeted Customer Segments: Banks are focusing on specific customer segments with tailored products and services. A bank launched special women’s account “Arise”.

• Premiumization of Services: Banks are focusing on premium customer segments. A bank has seen 42% YOY growth in Premium acquisitions in NTB Salary book by December 2024 and 26% YOY growth in Burgundy assets under management.

• Leverage opportunities through the value chain: Banks are also using opportunities through the value chain such as salary credits. A bank has seen 24% YOY growth in Salary Uploads in the NTB Salary book by Dec 24.

• Increase share of business with existing customers: Banks approach this by wanting customers to do as much of their banking as possible through them. Banks want a bigger portion of that share whether it is CA or SA or a fixed deposit.

Other observed strategies:

• Affluent and NRI Banking: Banks are showing robust traction amidst the challenging deposit environment through affluent and NRI banking.

• Customized solutions: Banks offer industry leading customized solutions across liquidity management, payments and collections continue to drive higher transaction banking flows leading to better current account balances.

These strategies indicate that banks are adapting to a changing economic landscape by prioritizing sustainable deposit growth, managing costs, and leveraging technology to enhance customer engagement and expand market reach.

5. Asset Quality: Overall Stability with Emerging Concerns

Overall Stability with Emerging Concerns:

While some banks maintain stable asset quality overall, there are emerging concerns, particularly in specific sectors like unsecured lending and microfinance. This suggests a bifurcated trend where the strength of secured portfolios is contrasted by increasing risks in certain unsecured segments.

Unsecured Lending:

• Rising Delinquencies: The transcripts indicate a general rise in delinquencies in unsecured products, including personal loans, credit cards and microfinance, across the industry. This is attributed to factors such as credit hungriness and over-leverage. One of the banks observed a rise in delinquencies in some pockets, specifically in unsecured products, including MFI, across the industry. The primary reasons are credit hungriness and over-leverage.

• Cautious Outlook: Given the heightened delinquency levels in the industry, banks are adopting a cautious stance toward unsecured lending.

• Proactive Interventions: Banks are implementing proactive measures, including regular portfolio monitoring and early warning triggers, to recalibrate policies and manage delinquencies within acceptable thresholds.

• Early signs of stabilisation: Stress in the credit card portfolio is now plateauing and therefore hopefully in the next couple of quarters it will actually see a decline.

Microfinance:

• Increased Slippages: Some banks have seen increased slippages in their microfinance portfolios. .

• Cautious Stance: Recent regulatory actions have led banks to adopt a cautious stance on the microfinance sector, both through direct and indirect sourcing.

• Not a Significant Portion: While there are concerns, microfinance does not constitute a significant portion of some banks' portfolios.

Corporate and Business Banking:

• Strong Performance: The corporate and business banking loan books continue to perform well for some banks.

• Low Slippages: Annualized slippages in the corporate book remain low and stable.

Provisioning and Recognition:

• Conservative Policies: Some banks claim to have conservative recognition and provisioning policies compared to their peers.

• 100% Provisioning: A key policy is to maintain 100% provisioning on unsecured retail loans once the loan turns NPA. One bank details unsecured gets written off at 150, which means if an account is not recoverable at 90, there is a very quick P&L take on that.

• Improved Recoveries: Recoveries from written-off accounts have improved, contributing to the provision line.

External Factors:

• Macroeconomic Conditions: Banks acknowledge that the macroeconomic environment impacts asset health, with slower growth potentially affecting customers' ability to repay loans.

• Geopolitical Environment: Banks continue to closely monitor the geopolitical environment, inflation, and liquidity.

• Seasonality: Seasonality impacts certain sectors, such as agriculture, leading to fluctuations in slippages.

Forward-Looking Strategies:

• Strengthening Collection Infrastructure: Banks are focused on strengthening their collection infrastructure, including using technology to improve collection capabilities.

• Prudent Underwriting: Banks are tightening underwriting norms and recalibrating policies to ensure delinquencies remain within acceptable thresholds.

• Focus on Secured Assets: Banks are focusing on secured assets and de-emphasizing unsecured lending to maintain a healthy portfolio.

Banks are generally maintaining stable asset quality, they are closely monitoring emerging risks, particularly in the unsecured lending space. Banks are implementing proactive measures to manage these risks and are preparing for potential challenges in the macroeconomic environment. The focus on secured lending, prudent underwriting, and strengthened collection efforts indicates a conservative approach aimed at ensuring long-term financial stability.

6. Credit Quality: Rising stress

Stable Performance in Specific Sectors Some banks report that their corporate and business banking loan books are performing well. For instance, one bank notes that its domestic corporate portfolio grew year-on-year. Additionally, annualised slippages in the corporate book remain low and stable. Another bank also shares that the secured book continues to have negligible delinquencies. This suggests that these banks have strong underwriting standards and effective monitoring mechanisms in place for their corporate clients.

Emerging Challenges in Unsecured Lending: Rising delinquencies in unsecured products, such as personal loans, credit cards and microfinance, across the industry. One of the banks observed a rise in delinquencies in some pockets, specifically in unsecured products, including MFI. This increase in delinquencies is attributed to factors such as credit hungriness and over-leverage.

Cautious Outlook on Microfinance The microfinance sector is also facing challenges, with some banks experiencing increased slippages in their microfinance portfolios. Recent regulatory actions have led banks to adopt a cautious stance on the microfinance sector, both through direct and indirect sourcing. However, it's important to note that microfinance may not constitute a significant portion of some banks' portfolios.

Proactive Risk Management In response to these challenges, banks are implementing proactive measures to manage risks. These measures include:

• Regular portfolio monitoring

• Early warning triggers

• Tightening of underwriting norms

• Recalibrating policies to ensure delinquencies remain within acceptable thresholds

Conservative Provisioning Policies Several banks emphasise their commitment to maintaining conservative provisioning policies to mitigate potential losses. These policies include:

• Maintaining 100% provisioning on unsecured retail loans once the loan turns NPA

• Writing off unsecured loans at 150 days past due

• Accelerated provisioning for accounts not recoverable within 90 days

Leading Indicators of Asset Quality Banks are closely monitoring various leading indicators to assess and manage asset quality. These include:

• SMA (Special Mention Accounts) 1 & 2

• Early bucket movements in both secured and unsecured portfolios

• Borrower behaviour

External Factors Influencing Asset Quality Several external factors are influencing the credit quality trends observed in the banking sector:

• Macroeconomic conditions: Banks acknowledge that the macroeconomic environment impacts asset health, with slower growth potentially affecting customers' ability to repay loans.

• Geopolitical environment: Banks continue to closely monitor the geopolitical environment, inflation and liquidity.

• Seasonality: Seasonality impacts certain sectors, such as agriculture, leading to fluctuations in slippages.

Specific Bank Strategies Different banks are adopting specific strategies to address the credit quality trends in their portfolios. For example, IndusInd Bank is reducing bulk deposits and focusing on retail LCR deposits to granularise their liabilities. Some banks are focused on secured assets and de-emphasising unsecured lending to maintain a healthy portfolio.

In summary, the credit quality trends in the banking sector reveal a mix of stability and emerging challenges. While corporate and business banking portfolios are generally performing well, unsecured lending and microfinance sectors are experiencing rising delinquencies. Banks are proactively managing these risks through prudent underwriting, strengthened collection efforts and conservative provisioning policies. They are also closely monitoring external factors, such as macroeconomic conditions and seasonality, to anticipate and mitigate potential challenges.